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BACKGROUND 
Introduction 
Smith-Magenis syndrome (SMS; OMIM# 182290) is a genetic disorder 
characterized by multiple congenital anomalies and mental retardation  most commonly 
caused by a 3.7- Mb deletion on human chromosome 17p11.2.  In addition, mutations in the 
RAI1 gene have also been described as a cause of SMS (Greenberg et al., 1996, Slager et al., 
2003).  Smith-Magenis syndrome was first described in 1982 and has an estimated 
prevalence of 1/25,000 births (Greenberg et al., 1991). Since its first description in 1982 and 
the publication of the spectrum of clinical features by Smith et al. in 1986, the more subtle 
features of this syndrome have been delineated.   Individuals with SMS encompass a 
phenotypic spectrum that includes congenital anomalies, characteristic craniofacial features, 
growth abnormalities, mental retardation and a distinctive neurobehavioral profile.   
History of Smith-Magenis syndrome  
The first official account of what is now known as Smith-Magenis syndrome was 
published in the American Journal of Human Genetics in 1982.  Smith et al. reported two 
unrelated males with facial clefts and congenital heart disease.  The first individual carried a 
diagnosis of Pierre Robin sequence, a ventricular septal defect (VSD), congenital heart 
block, skeletal abnormalities and hearing loss (Smith et al., 1986).  Individual number one 
died at six months of age from complications related to surgical repair of his VSD (Smith et 
al., 1986).  The second individual had bilateral cleft lip and palate and VSD.  Both of the 
individuals were diagnosed with failure to thrive (FTT) and were less than the 3rd percentile 
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for their growth parameters.  Cytogenetic analysis revealed that both of these individuals 
had an interstitial deletion of the p11 band on chromosome 17 (Smith et al., 1982).  
A follow-up article published in 1986 by Smith et al. provided detailed case reports 
of seven newly identified and two previously identified individuals with congenital heart 
defects and facial clefts.  Cytogenetic analysis of these nine cases revealed, all had at a 
minimum, a small interstitial deletion in 17p11.2 and individual 1, the most severely 
affected of the cases reported, was deleted for the entire 17p11.2 band (Smith et al., 1986).  
The phenotypes of the individuals were compared and the majority of individuals had the 
following: brachycephaly, midface hypoplasia, broad nasal bridge, prognathism, short 
stature, scoliosis, speech delay, behavior problems and mental retardation (Smith et al., 
1986).   
Smith et al. 1986 were the first to report that the prognathism present in SMS 
individuals is “age dependent.”  They observed the two youngest patients in their cohort had 
micrognathia, where as prognathism was present in the older patients. The most commonly 
described features included: speech delay, which was present in seven of eight (87.5%) 
living patients, a hoarse deep voice was identified in four of eight (50%) individuals and 
hearing loss was present in six of nine (66.67 %) individuals.  They also found that seven of 
eight (87.5%) living individuals had similar behavioral problems that began in early 
childhood including hyperactivity and self-destructive behaviors (Smith et al., 1986).   
At the time of the Smith et al. publication in 1986, there were seven additional 
individuals with 17p11.2 deletions with similar phenotypes to those described by Smith et 
al. reported in the medical literature (Patil and Bartley, 1984; Stratton et al., 1986.)  Since 
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the initial publications by Smith et al., several different groups of researchers have 
contributed invaluable information to the field of SMS research. One of these such groups 
was lead by Doctors Greenberg and Lupski at Baylor College of Medicine and Texas 
Children’s Hospital through a multidisciplinary clinical study of individuals with SMS.  The 
results of this study, published by Greenberg et al. in 1991 and 1996, provided phenotypic 
information on a cohort of individuals with SMS. Their examination of individuals with 
SMS confirmed the common clinical features and provided information on features that had 
never been reported in individuals with Smith-Magenis syndrome.  
Since 1997 another group of researchers at the NIH/NHGRI have been conducting a 
study of the natural history of SMS with the goals of further characterizing the phenotype to 
ensure increased recognition of the syndrome and earlier diagnosis.  They have also been 
working to develop therapies and interventions to treat the developmental delays and 
behavioral abnormalities seen in individuals with SMS.  The 2006 publication by Gropman 
et al. provided a comprehensive review of the SMS phenotype using data collected from the 
NIH natural history study.       
Clinical Findings                                                  
Congenital Anomalies 
Although congenital anomalies are not present in all individuals with SMS, the most 
common congenital anomalies are cleft lip with or without cleft palate, renal/urinary tract 
abnormalities and cardiac defects. Renal abnormalities were present in two of nine (22 %) of 
individuals studied by Smith et al. 1986.  One individual was found to have bilateral 
ureterovesicular obstruction and a second individual was found to have a single hypertrophic 
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right kidney with malposition of the ureterovesicular junction.  The prevalence of renal and 
urinary tract abnormalities in the Greenberg SMS cohort was 34.6% and included the 
following abnormalities: duplication of the collecting system, unilateral renal agenesis and 
ectopic kidney (Greenberg et al., 1996). Due to the high prevalence of renal and urinary tract 
abnormalities, renal ultrasounds should be performed following a diagnosis of SMS to 
ensure appropriate treatment and surgical correction if necessary.   
Five out of twelve (43%) individuals studied by echocardiography by Greenberg et 
al., 1996 were found to have cardiac anomalies that included: mild tricuspid regurgitation, 
mild mitral regurgitation, subvalvular aortic stenosis, VSD and supravalvular pulmonic 
stenosis. Four individuals had been diagnosed with a cardiac abnormality previously and 
these abnormalities included pulmonic stenosis, VSD, mitral valve prolapse and an ASD. 
Ten of twenty-seven (37%) individuals evaluated in the Greenberg SMS cohort were found 
to have cardiac anomalies.  Due to the high prevalence of congenital heart defects in 
individuals with SMS, echocardiogram should be performed following the initial diagnosis 
and if a heart defect is identified, surgical repair is indicated.   
Craniofacial 
The facial appearance of individuals with SMS, though distinct, can vary between 
infancy and adulthood.  Infants with SMS may only display subtle dysmorphic facial 
features including a broad, square shaped face with mid-face hypoplasia, while adolescents 
and adults with SMS show more pronounced dysmorphic facial features (Gropman et al., 
2006).  In addition to the broad, square-shaped face, adults with SMS can have 
brachycephaly, midface hypoplasia, tented upper lip, up-slanting palpebral fissures, deep-set 
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eyes, short full-tipped nose and prognathism (Greenberg et al., 1991). The facial features 
present in adults with SMS have also been described as coarse with deep-set eyes, relative 
prognathism, heavy brows and synophyrs (Allanson, Greenberg, & Smith, 1999) 
Growth and Development 
 To assess the SMS phenotype during infancy Gropman, Duncan & Smith (2006) 
performed medical histories and physical exams, and analyzed parent questionnaires and 
medical records  of patients 24 months or older.  They found that the weight, length and 
FOC of infants with SMS are within normal limits at birth. However, at approximately 12 
months of life, infants with SMS begin to show features of failure to thrive (FTT) including 
poor weight gain and poor linear growth (Gropman, Duncan, & Smith, 2006; Greenberg et 
al., 1991).  The FTT was thought to be related to the oral motor dysfunction present in all 
infants studied as well as hypotonia, lethargy, increased sleepiness and daytime napping 
(Gropman, Smith, Allanson, & Greenberg, 1998).  It was also reported that all infants 
studied showed some degree of oral motor dysfunction, with poor feeding being present in 
some (Gropman, Duncan, & Smith, 2006).  
All infants studied by Gropman, Duncan & Smith., in their 2006 publication also had 
motor delays and decreased crying and babbling but were within normal limits, or only 
slightly delayed for their social-emotional function. 
Sleep Disturbances  
 Prior to childhood, the sleep patterns of infants with SMS are not characterized as 
problematic or troublesome.  In fact, many parents of SMS infants describe them as “perfect 
babies” (Gropman et al., 2006).  It is during childhood that characteristic sleep disturbances 
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of SMS become evident. However, retrospective analysis has found sleep abnormalities are 
present in infants with SMS (Greenberg et al, 1991). Infants with SMS have “excessive 
daytime sleepiness” and decreased 24-hour sleep (Greenberg et al., 1991). In the Greenberg 
et al. 1991 cohort, 62% of individuals showed signs of a sleep disorder that included 
difficulty falling asleep, staying asleep, and frequent awaking during the night. They also 
reported that REM sleep was absent in two individuals studied by polysomnography.  In 
1996, Greenberg et al., reported of the 24 individuals who underwent sleep studies, 29% 
patients had decreased sleep time due to frequent night-time awakening. Decreased rapid 
eye movement (REM) sleep was found in 12 of 24 (50%) individuals, normal REM sleep 
was found in 11 of 24 (45.8%) individuals and one patient (4 %) had increased REM sleep.  
Greenberg et al. reported all individuals studied had problems falling and staying asleep 
throughout the night.  They concluded that there was a defect in REM sleep but were unsure 
of the underlying mechanism.   
DeLeersnyder et al., in 2001 measured the plasma concentrations of melatonin over a 
24-hour period in 20 subjects with SMS as well as their age matched controls.  Their results 
showed individuals with SMS had different melatonin cycling when compared to their age 
matched controls. Typically the circadian rhythm functions such that melatonin is low 
during the day light hours, however as darkness sets, the pineal gland begins to produce 
melatonin indicating to the body that it is time to sleep.   In individuals with SMS, their 
melatonin secretion began at 6 AM + 2 hours, their levels peaked at 12 PM + 1 hour and 
their offset occurred at 8 PM + 1 hour (DeLeersnyder et al., in 2001).  This is in contrast to 
the melatonin cycling seen in their age matched controls who experienced onset of secretion 
at 9 PM + 2 hours, peak of secretion at 3:30 AM + 1.30 hours and offset of melatonin at 6 
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AM + 1 hour.  DeLeersnyder et al., also found a positive correlation between the frequency 
of a SMS child’s tantrums and increasing daytime melatonin levels.  As the amount of 
melatonin increased during the day, the frequency of tantrums in individuals with SMS 
increased as well.  DeLeersnyder et al. hypothesized the behavioral problems could be 
aggravated by the fact that children with SMS have elevated melatonin levels during the 
daytime and that their daytime sleepiness could be causing or contributing to their 
behavioral problems.     
Since these abnormalities in melatonin cycling have been discovered, researchers 
have attempted to treat the sleep disturbances by using melatonin and acebutolol an oral 
beta-1-adrengeric antagonist.  A trial conducted by De Leersynder et al. in 2003 studied the 
daytime usage of acebutolol and an evening dose of 6 mg of melatonin. This dosage pattern 
was able to increase the nocturnal melatonin levels, improve nighttime sleep and decrease 
daytime sleepiness and improve overall daytime behavior (Leersynder et al. in 2003).   
The sleep disturbances present in children with SMS present a management 
challenge. No well controlled treatment trials have been conducted. There is currently no 
standard of care or management protocol to control the sleep disturbances in children with 
SMS.    
Neurobehavioral 
The neurobehavioral abnormalities present in SMS are a distinctive component of its 
clinical phenotype.  Self-destructive behavior was present in 67% of individuals described 
by Greenberg et al. in 1991. The neurobehavioral profile of 29 individuals with SMS was 
studied and self-injurious behaviors were present in 96.6% of individuals (Finucane, Dirrigi, 
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& Simon, 2001). Individuals with SMS exhibit the following: hyperactivity, sleep 
disturbances, temper tantrums, attention seeking, self-hitting, self-biting, self-hugging, 
polyembolokoilamania (inserting foreign bodies into body orifices) and onychontillomania 
(pulling out one's fingernails)  (Greenberg et al., 1991). Greenberg et al. also reported self-
destructive behaviors such as head banging and wrist biting are present as early as 2 years of 
age; but, more severe behavior such as onychotillomania does not present until 5-6 years of 
age. The stereotypic and self-injurious behaviors present in SMS are so unique that they are 
a major clue for diagnosis as they are distinguishable from other genetic syndromes 
associated with mental retardation.  There is a direct correlation between the severity of self-
injurious behaviors and the level of intellectual functioning in individuals with SMS 
(Finucane, Dirrigi, & Simon, 2001). 
SMS shares common features with those seen in Prader-Willi syndrome (PWS; 
OMIM 176270) and before much was known about SMS, some individuals with SMS were 
misdiagnosed as having PWS (Dykens & Smith, 1998).  As first published by Greenberg et 
al., the overlapping features of PWS and SMS include the following: infantile hypotonia, 
short stature, skin picking, sleep disturbances and behavioral abnormalities.  Greenberg et 
al., 1996 also noted that individuals with SMS also have hyperphagia (Greenberg et al., 
1996b).  Although there continues to be overlap of the PWS and SMS phenotypes, there are 
certain features now know to be unique to each of these syndromes (Dykens & Smith, 
1998).  In a study comparing the neurobehavioral abnormalities of PWS and SMS, 
individuals with PWS were found to have higher levels of obsessive food related thoughts 
(Dykens & Smith, 1998).  SMS individuals were also found to show obsessive thinking but 
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these thoughts were not necessarily always realted to food and were more often related to 
“specific topics or events” (Dykens & Smith, 1998). 
Cognitive 
Although varying degrees of mental capacity are seen, adolescents and adults with 
SMS continue to experience cognitive delays and the majority of individuals have moderate 
mental retardation (Greenberg et al. 1991). Behavioral abnormalities continue to become 
more pronounced during adolescence and remain constant throughout adulthood. 
Adolescents with SMS experience aggressive and explosive outbursts, attention seeking 
behaviors and impulsive, disobedient actions. They continue to engage in the self-injurious 
behaviors that began in childhood (Dykens & Smith, 1998).  
Most individuals with SMS are not able to live on their own as adults and require 
supervision from caregivers to ensure that their daily needs are met. Lifespan is not thought 
to be different than other individuals with mental retardation and there is no decline in 
cognitive abilities (Dykens and Smith 1998).  The oldest individual known to have SMS 
died at the age of 88 from a stroke (http://www.ncbi.nlm.nih.gov/sites/GeneTests; 04/09/10).  
 As part of the multidisciplinary study conducted by Greenberg et al., imaging 
studies were performed on individuals with SMS to determine whether or not brain 
malformations contributed to their neurobehavioral phenotype and mental retardation. Brain 
MRI showed abnormalities in 13 individuals that included findings of ventriculomegaly and 
enlarged cisterna magna; both of which were considered clinically insignificant (Greenberg 
et al., 1991, Greenberg et al., 1996a).  Based on these insignificant findings, researchers 
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were able to conclude the cognitive impairments and behavioral abnormalities in individuals 
with SMS were not attributed to brain malformations.   
Other Phenotypic Findings  
The following describes abnormalities that are occasionally seen in individuals with 
SMS and warrant evaluation during annual physical examination.  Ophthalmologic 
abnormalities were seen in 23 out of 27 individuals studied by Greenberg et al in 1991. 
These abnormalities included strabismus, myopia, microcornea, iris dysplasia, nasal 
corectopia and iris coloboma.  Hearing loss has also been described in individuals with 
SMS, therefore periodic audiologic evaluation is recommended. Of twenty-five patients who 
underwent audiologic evaluations 10 individuals were found to have conductive hearing 
loss, 5 were found to have sensorineural hearing loss and 2 had mixed hearing loss; giving a 
combined prevalence of hearing impairment of 68%   (Greenberg et al., 1991; Potocki, 
Shaw, Stankiewicz, & Lupski, 2003)). Hearing loss was also present in the two individuals 
first described with SMS (Smith et al., 1982). Individuals with SMS can also develop 
scoliosis. Mild to moderate thoracic scoliosis was present in 13 of 20 or 65% of patients 
greater than 4 years of age (Greenberg et al., 1991; Potocki, Shaw, Stankiewicz, & Lupski, 
2003). More recent data suggests that vertebral anomalies and scoliosis are present in 
approximately 60% of SMS individuals and thus spine radiographs are needed to evaluate 
for these conditions.    
Diagnosis 
The diagnosis of SMS was first made using routine G banded cytogenetic 
techniques. However this method missed a large number of deletions that were not visible 
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using standard cytogenetic technology. Fluorescence in-situ hybridization (FISH) was able 
to identify smaller deletions in 17p11.2. With the development of array comparative 
genomic hybridization (array CGH), many individuals with smaller deletions in 17p11.2 that 
would have been missed using FISH technologies have been identified on array CGH.  
Array CGH, also known as chromosomal microarray or whole genome array has now 
become the primary method of diagnosis of SMS.  Even with the advances that have been 
made in array CGH technologies, there remains a subset of patients who meet SMS clinical 
criteria who do not have identifiable deletions of 17p11.2. In individuals with the clinical 
phenotype of SMS without identifiable deletions in 17p11.2, mutation analysis of the RAI1 
gene should be performed.  
Genetics of Smith Magenis syndrome 
Smith-Magenis syndrome (SMS; OMIM# 182290) is a genetic disorder that is 
caused by a deletion on human chromosome 17p11.2 or a mutation in the RAI1 gene 
(Greenberg et al., 1996, Slager et al., 2003).  SMS is thought to be continguous-gene 
deletion syndrome (CGS). Contiguous-gene deletion syndromes can cause both 
microduplications and microdeletions due to misalignment of homologous chromosomes.  
Although both small (approximately 1.5 Mb) and large (approximately 9 Mb) deletions of 
17p11.2 have been reported in SMS patients, 75% of individuals have a common 3.5 Mb 
deletion in this region (Trask et al., 1996).  The minimum deletion region is approximately 
700 kB in size (Girirajan et al., 2005). In addition, it is also known that mutations in the 
RAI1 gene result in an SMS phenotype (Slager et al., 2003.) 
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Low Copy repeats 
In 1997 Chen et al., discovered homologous recombination between flanking SMS-
REP repeat-gene clusters was the molecular basis for the SMS common deletion. Low copy 
repeats have been implicated in the molecular basis of several genetic conditions including 
DiGeorge/velo-cardialfacial syndrome, Prader-Willi/Angelman syndrome and Williams 
syndrome. Genetic diseases, caused by microdeletions or microduplications occur when 
there is nonallelic homolgous recombination (NAHR) between the low-copy repeats (LCR) 
gene clusters during maternal and paternal gametogenesis (Erdogan, Chen, Kirchhoff et al., 
2006).   
Discovery of RAI1 
Girirajan et al., (2005) were able to define the critical region of SMS to a ~700 kb 
region that was commonly deleted in all SMS patients with deletions in 17p11.2.  Further 
study of this region led researchers to discover that there were small deletions present within 
the RAI1 gene in patients who did not have deletions in 17p11.2 detectable by FISH (Slager 
et al 2003).  In 2003 it was discovered that dominant frameshift mutations in the retinoic 
acid inducible 1(RAI1) gene were present in three individuals who had clinical features of 
SMS but did not have 17p11.2 deletions present (Slager et al., 2003). Further studies have 
identified additional individuals with the “hallmark” clinical features of SMS including 
developmental delay, sleep disturbances and self injurious behavior with deletions in RAI1.  
In 2005, Girirajan et al. summarized the findings of all of the individuals found to have 
mutations in RAI1 and found that none of these individuals with RAI1 mutations had the less 
common features seen in individuals with SMS including heart defects, urinary system 
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malformations or other birth defects. These data lead researchers to postulate that 
haploinsufficiency of RAI1 is responsible for the behavioral, neurological, otolaryngological 
and craniofacial features of SMS and more variable features including congenital defects are 
caused by hemizygosity of other genes in the 17p11.2 region (Slager et al., 2003).  
RAI1 
 At the time of its discovery in 2003, researchers were uncertain of the clinical roles 
of RAI1. Since 2003, researchers have discovered the RNA product of RAI1 is expressed in 
all tissues studied and was present in high levels in the heart and neuronal structures (Slager 
et al., 2003; Toulouse, Rochefort, Roussel, Joober, & Rouleau, 2003). The RAI1 gene is 
highly conserved throughout mammalian evolution. The current hypothesis regarding the 
function of the RAI1gene is that RAI1 is a transcriptional regulator involved in the 
development of neurons but its exact function is unknown (Girirajan et al., 2005).  
SMS Mouse Models 
 Mouse models of SMS, del(17)(p11.2p11.2) and the Potocki-Lupski syndrome, 
dup(17)(p11.2p11.2) (PTLS; OMIM#610883)  the recombination reciprocal of the SMS 
deletion, have been created to further understand the phenotypes of the two syndromes.  
Human chromosome 17p11.2 is syntenic to a 32-to-34 cM region on mouse chromosome 11. 
The critical interval for SMS is a ~1-Mb region that includes 19 genes that are conserved in 
the same order and orientation in mice (Bi et al., 2002). Studies performed in the SMS mice, 
Df(11)17/+  and the PTLS mice, Dp(11)17/+   have demonstrated differences in the growth 
patterns consistent with what is reported in humans with SMS and PTLS.   
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An important finding of studies of mice with SMS and PTLS are the differences in 
body weight first reported by Walz et al., in 2003. During the first month of life the 
Dp(11)17/+ and Df(11)17/+ mice were both significantly lower in weight when compared 
to their wild-type litter mates. The PTLS mice, Dp(11)17/+, remained underweight 
throughout their lives and the homozygous duplication mice Dp(11)17/Dp(11)17 were 
significantly underweight, even compared to the heterozygous duplication mice, 
Dp(11)17/+.  Starting at 4 months of age, the SMS mice Df(11)17/+, were significantly 
overweight when compared to the wild-type mice. By 8 months of age the Df(11)17/+ mice 
weighed more than 60g, whereas the  wild-type mice weighed approximately 30g. The 
abdominal fat contents were also compared between the different genotypes. The 
Df(11)17/+ mice had an average abdominal fat content of 1.93 + 0.20g.  The Dp(11)17/+ 
mice had an average abdominal fat content of 0.30g + 0.06g and the wild-type mice had an 
average abdominal fat content of 0.56g + 0.05g. The amount of abdominal fat made up 4.5% 
of the total body weight in Df(11)17/+ mice, 1.2 % of the total body weight of the 
Dp(11)17/+ mice and 2.0% of the total body weight of the wild-type mice. When the 
Df(11)17/ Dp(11)17 mice were studied they were found to have weights similar to that of 
the wild-type mice. This finding suggests that the presence of the wild-type number of genes 
can rescue the overweight phenotype of the Df(11)17/+ mice and the underweight 
phenotype of the Dp(11)17/+ mice (Walz et al., 2003. 
In addition to describing the weight differences between the deletion and duplication 
mice, there is also data available about other phenotypic characteristics. It is known that the 
craniofacial features of SMS become more pronounced as an affected individual ages. The 
craniofacial features of the Df(11)17/+ mice have been documented throughout the life span 
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of the mouse.  No craniofacial abnormalities were appreciated during the newborn period of 
Df(11)17/+ mice when compared to wild-type mice.   All of the adult Df(11)17/+ mice were 
found to have craniofacial abnormalities including shorter skull lengths, broader and shorter 
snouts and distinctive nasal bone shape. Congenital heart defects, urinary tract defects and 
seizures have been reported in 35%, 29% and 19% of individuals with SMS respectively 
(Chen et al., 1997 and Greenberg et al., 1996).  No defects were found in the heart or urinary 
system of Df(11)17/+  or Dp(11)17/+ mice.  Seizures and abnormal EEGs were present in 
Df(11)17/+ mice. This finding led researchers to postulate that there was a direct effect of 
the deletion on neuronal excitability (Walz et al., 2003).  Seizures were not present in the 
Dp(11)17/+ mice.    
 Before haploinsufficiency of RAI1 was determined to be responsible for major 
features of SMS, a mouse model with a null mutation in RAI1 was created to study the 
relationship between the RAI1 copy number and the Df(11)17/+  and Dp(11)17/+  
phenotypes.  The weights of the Rai1+/- mice were measured from 3 weeks to 7 months.  At 
4-7 weeks of age the Rai1+/- mice were underweight when compared to their wild-type 
litter mates.  However, by 23 weeks of age both male and female Rai1+/- mice were 
overweight when compared to their wild-type littermates.  Researchers were able to 
conclude that haploinsufficiency of Rai1 was a major factor in the obesity that is present in 
SMS individuals (Bi et al., 2005).  
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Obesity 
In the General Population 
The negative health, economic, and social consequences of obesity are well 
documented.  The American Medical Association considers obesity the fastest growing 
health problem in the United States.  Obesity kills more than 300,000 Americans per year, 
which is more than AIDS, all cancers and all accidents combined. More than 66% of the 
adult population in the United States is overweight or obese (Ogden, Carroll, Curtin, 
McDowell, Tabak, & Flegal, 2006). More frightening than the facts about obesity in US 
adults, are the statistics about overweight and obese children.  The prevalence of overweight 
and obesity in US children has tripled over the past two decades (Ogden, Carroll, Curtin, 
McDowell, Tabak, & Flegal, 2006)  
Overweight and obesity have been shown to increase morbidity/mortality and 
decrease life expectancy.  The health risks associated with obesity include: insulin 
resistance, type 2 diabetes, hyperlipidemia, hypertension, coronary heart disease, congestive 
heart failure and gastrointestinal complications including gastroesophageal reflux, gallstones 
and gallbladder disease, gout and non-alcoholic fatty liver disease (Pi-Sunyer, 1991).  
Overweight and obese individuals are at increased risks for developing certain types of 
cancer including: endometrial, colon, kidney, gallbladder and postmenopausal breast cancer 
(Krebs et al., 2007).   In addition to the physical risks associated with overweight and 
obesity, there are also emotional and psychosocial risks that are often under appreciated.  
Overweight and obese individuals have increased risks for depression, low self-esteem, poor 
self-image and social isolation (Krebs et al., 2007).  
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As with most health conditions, family history is important in determining a child’s 
risk to develop obesity and the strongest predicator of childhood obesity is the weight status 
of the parents.  If one parent is obese, the odds ratio that a child will be obese as an adult is 
3:1. This odds ratio jumps to 10:1 if both parents are obese (Whitaker, Wright, Pepe, Seidel, 
& Dietz, 1997).  It is thought that the relationship between parental and childhood obesity is 
multi-factorial in etiology, with multiple genes and environmental factors playing a role.  
Genome wide association studies have been performed to gain more information about 
genes that are associated with obesity. The results of these studies showed that obesity is 
polygenic, with more than 300 genes and genetic loci associated with obesity (Chagnon, 
Rankinen, Snyder, Weisnagel, Perusse, & Bouchard, 2003).  Additionally, there are 50 loci 
related to Mendelian syndromes associated with obesity that have been mapped (Rankinen, 
et al., 2006). 
In Genetic Conditions 
It is well documented that obesity and food seeking behaviors are present in certain 
genetic conditions associated with cognitive impairment. Prader- Willi syndrome (PWS; 
OMIM 176270) is an example of a genetic condition that is primarily associated with 
obesity, cognitive impairments, maladaptive behaviors and hyperphagia, an abnormally 
increased appetite for and consumption of food (Dykens, Maxwell, Pantino, Kossler, & 
Roof, 2007).  
Although the negative effects of obesity in the general population are well known, 
little is known about the prevalence or cause of any obesity that is present in the SMS 
population.   In more recent studies of SMS individuals, a new concern for the involvement 
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of obesity has been raised.  Of those studies that have been published, information obtained 
was often incomplete and small in number.  Because so little is available, it is not clearly 
defined how obesity is involved in the natural history of this condition.   
An abstract presented by Smith et al. in 2004 provided an overview of parametric 
measurements of growth and body mass index (BMI) of 54 individuals with SMS. BMI is a 
measurement of weight in relation to height that is used to determine if an individual is 
overweight or obese. BMI is calculated in the following manner: BMI= weight (kg)/height 
(m2). In adults, normal weight is defined as a BMI between 18.5- 24.9, underweight is 
classified as a BMI less than 18.5, overweight is defined as a BMI of 25-29.9 and obesity is 
defined as a BMI of 30 or greater.   In the abstract presented by Smith et al., the mean birth 
weight was between the 5th -25th percentile and birth length was between the 25th- 50th 
percentiles. They reported that poor growth, as defined by <5th percentile, was noted within 
the first six months of age and that it may persist into early childhood. The abstract also 
reported that on average, males with SMS were at the 25th percentile for weight at age 6 
years and grew to the 90th percentile by 14 years. Females with SMS were reported to be 
between the 25-50th percentile for weight between the ages of 1- 7 years and increased to 
>90th percentile by age 12 (Smith, Leonard, Gropman, & Krashewich, 2004). Another study 
investigating hypercholesterolemia in 49 individuals with SMS reported the mean BMI in 
individuals with SMS was 18.43 with a range of 14.08- 31.67 (Smith, et al., 2002). A meta- 
analysis of 105 individuals with SMS published in 2007 provided valuable information 
about genotype-phenotype information in individuals with SMS (Edelman, et al., 2007). 
However information regarding growth and BMI was unavailable for over 60% of the cases 
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examined. Because of these conflicting findings, further studies regarding the role of obesity 
in the Smith-Magenis population are needed. 
The severe neurobehavioral abnormalities present in individuals with SMS make this 
facet of the phenotype an interesting avenue to explore in an attempt to provide an 
explanation of the obesity seen in individuals with SMS. Therefore the specific aims of this 
study are to: 
1.) Characterize the growth (height, weight and BMI) of a cohort of individuals with 
Smith-Magenis syndrome to determine if obesity is a component of SMS in our 
patient population. 
2.) Assess if hyperphagia or food seeking behaviors are present in individuals with 
Smith-Magenis syndrome. 
 Determining whether or not neurobehavioral abnormalities such as food seeking 
behaviors and hyperphagia are present in individuals with SMS would aid in further 
characterizing the natural history of this genetic syndrome. In addition, if obesity and 
behavioral components can be characterized, targeted and age appropriate therapies can be 
developed in order to better manage individuals with SMS.  
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MATERIALS & METHODS 
This study used two methods of data collection in order to addresses the two specific 
aims. Part I of the study aims to characterize the growth (height, weight and BMI) of a 
cohort of individual with Smith-Magenis syndrome to determine the prevalence of obesity 
through the use of a retrospective chart review.  Part II of this study aims to assess if 
hyperphagia or related behaviors are present in individuals with SMS through the use of a 
parent questionnaire which includes a validated instrument, the Hyperphagia Questionnaire 
(Dykens et al., 2007).  This study was approved by the University of Texas Health Science 
Center Committee for the Protection of the Human Subjects (HSC-GEN-09-0393) and the 
Institutional Review Board for Baylor College of Medicine and Affiliated Hospitals (H-
25766).  A consent form was required and was mailed to participants along with the study 
questionnaire. 
Participants   
There were essentially two different sets of participants in this study.  For Part I of 
the study, the retrospective chart review, participants were individuals with a confirmed 
medical diagnosis of Smith-Magenis syndrome by chromosome analysis, fluorescence in 
situ hybridization (FISH) or array CGH (aCGH).  For Part II of the study, the assessment of 
hyperphagia and related food seeking behaviors, all participants were parents or caregivers 
of individuals with a confirmed medical diagnosis of Smith-Magenis syndrome.  
Participants were ascertained through a database of SMS patients maintained by Baylor 
College of Medicine (BCM) at Texas Children’s Hospital (TCH).  All participants whose 
child carried a confirmed medical diagnosis of SMS had either:  
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1.) Participated in or contacted researchers regarding participation in clinical 
research at BCM/TCH, or: 
2.) Have been, or are, currently followed in the genetics clinic at Texas Children’s 
Hospital 
 Individuals without a confirmed medical diagnosis of SMS were not included in the 
retrospective chart review, nor were their parents mailed a study questionnaire.   
Procedure 
In Part I of this study, a retrospective chart review was conducted of participant’s 
medical records.  Sources of available information included: electronic medical record, 
paper charts and research charts.  All documented height and weight measurements were 
abstracted for each individual.  This data was collected by hand, matched with the 
individual’s unique study ID and entered into an Excel database.  
For Part II of this study, a questionnaire was mailed to the corresponding parents of 
individuals in Part I of the study. Each household was limited to one questionnaire and the 
questionnaire was to be filled out by only one parent/caregiver.   A total of eighty-nine 
questionnaires were mailed; twenty-two questionnaires were returned without a forwarding 
address for a total of seventy-seven potential participants.  Twenty-five completed 
questionnaires were returned, corresponding to a response rate of 28% (25 out of 89). 
Questionnaires were initially mailed in October 2009 and data was collected through March 
2010. 
The questionnaire consisted of 51 questions subdivided into five sections.  Section 1, 
a set of 10 demographic questions, provided demographic information regarding the parent 
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completing the questionnaire.  The remaining four sections of the questionnaire provided 
information regarding the individual with SMS.  Section 2 consisted of 15 medical and 
social history questions, Section 3 consisted of 3 exercise history questioned and Section 4 
consisted of 10 diet history questions.  The final 13 questions were taken from a validated 
hyperphagia questionnaire (HQ), developed by Elizabeth Dykens, PhD.  
The HQ was initially developed to assess hyperphagia in individuals with Prader--
Will syndrome (PWS) (Dykens, Maxwell, Pantino, Kossler, & Roof, 2007). This 
questionnaire has been validated in the Prader-Willi population and has also been used in 
individuals with Down syndrome and undiagnosed intellectual disabilities who show food 
seeking behaviors or “Prader--Willi-like” preoccupations with food.  Dr. Dykens has given 
permission via email for the use of the hyperphagia questionnaire in this research project. 
The HQ was created to measure hyperphagia in individuals with PWS by looking at the 
following: specific food related behaviors, preoccupations and thoughts about food and the 
severity of the symptoms.  Responses on the HQ are rated on a 5 point scale (1 = not a 
problem to 5 = severe and/or frequent problem.)  In their initial publication describing the 
use of the HQ in 153 individuals with PWS, Dykens et al. conducted a factor analysis and 
found three factors emerged which accounted for 58.93% of the variance seen in 
hyperphagia  (Dykens, Maxwell, Pantino, Kossler, & Roof, 2007).  These factors were 
labeled, Hyperphagic Behavior, which accounted for 34.47% of the variance (eigenvalue = 
3.79, Cronbach’s alpha = 0.76), Hyperphagic Drive, which accounted for 15.28% of the 
variance (eigenvalue = 1.68, Cronbach’s alpha of 0.80) and Hyperphagic Severity which 
accounted for 9.17% of the variance (eigenvalue = 1.01, Cronbach’s alpha = 0.60). There 
were two questions on the questionnaire that did not load onto any factor and these items 
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were: age of onset of hyperphagia and variability in the drive for food.  As these items did 
not specifically correlate with factor, they were dropped from further analysis (Dykens et al., 
2007).   
Individuals who completed and returned the questionnaire were eligible to receive a 
$15 gift certificate to Target®. The financial support for this project (including postage, the 
printing of study related materials and incentive) was provided by a donation received by 
Dr. Potocki to investigate obesity in individuals with SMS.   
Analysis: 
Part I- Retrospective Chart Review 
Based on their age at their last recorded measurement, individuals were categorized 
into age groups using the classifications provided by the CDC.  Table 1 provides an 
overview of the age classification system used in this study.   
 
 
 
 
 
 
 
Table. 1  Age Classifications 
Age Group Corresponding Age  
1 0-23 months 
2 2-5 years 
3 6-11 years 
4 12-19 years 
5 ≥ 20 years  
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Z-scores 
For all growth measurements, including those obtained from the parent questionnaire 
and chart review, Z-scores (SD units) for height-for-age, length-for-age and BMI-for-age 
were calculated using the reference growth standards provided by National Center for 
Health statistics and the Centers for Disease Control and Prevention (Statistics, N.C.f.H., 
2000). The calculation of Z-scores allowed for comparison between the SMS patient 
population and the reference standard as defined by the CDC.  For individuals less than 20 
years of age, the Z-scores were calculated using the values provided by the CDC 
corresponding to their given age and gender.  For individuals greater than or equal to 20 
years of age, Z-scores were calculated using the values provided by the CDC corresponding 
to that of a nineteen year old of their respective gender.  One sample t-tests were run to 
assess for differences in the weight-for age, height for age and BMI-for age Z-scores 
between our SMS cohort and reference standards.    
BMI 
BMI was calculated for all individuals ≥ 24 months of age using the following 
formula: BMI = weight (kg)/ [height(m)2].   For individuals < 20 years of age (age 24 
months through 19 years of age) BMI and BMI percentile were calculated.  It was necessary 
to calculate BMI percent in order to interpret the BMI of individuals less than 20 years of 
age, as the interpretation of BMI during childhood and adolescence is different than the 
interpretation of BMI in adulthood.  The interpretation of BMI in childhood is dependent on 
age and gender.  For individuals greater than 20 years of age, BMI was calculated and 
interpreted using the CDC’s recommendation for the interpretation of BMI in adults.  
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Through the use of BMI, individuals were classified as underweight, healthy weight, 
overweight or obese.  Table 2 provides an explanation of the interpretations of BMI in 
individuals’ ≥ 2 and < 19 years of age.  Table 3 provides an explanation of the 
interpretations of BMI in individuals’ ≥ 20 years of age.    
 
 
 
 
 
  
Part II- Parent Questionnaire  
The data obtained from the non-validated portion of the questionnaire was entered 
into an Excel database and descriptive statistics were performed for the following: 
participant demographics (parents of children with SMS), affected child’s medical, social, 
exercise and diet history.   
Hyperphagia Questionnaire  
The hyperphagia questionnaire used in Part II of the study was scored according to 
the validated parameters. As the HQ is scored on a Likert scale, mean scores were calculated 
for each question in the HQ.   Individuals were also given a mean score for the three factors 
Table 2. BMI-for-Age 
Individuals age ≥ 2 years & < 20 years of age 
Weight Status 
Category 
Percentile Range 
Underweight  < 5th percentile 
Healthy weight 5th percentile through < 
85th percentile  
Overweight 85th percentile to less 
than 95th percentile  
Obese ≥ 95th percentile  
 
Table 3. BMI in Adults 
Individuals ≥20 years of age 
Weight Status 
Category 
BMI 
Underweight < 18.5 
Healthy weight 18.5-24.9 
Overweight 25.0-29.9 
Obese 30.0 and above 
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present in the HQ: hyperphagic behavior, hyperphagic drive and hyperphagic severity.  The 
mean scores for the three factors were compared using the following variables: age, gender 
and BMI.  Two sample t-tests were calculated to assess for differences between the mean 
HQ scores between individuals who were healthy weight and obese weight, overweight and 
obese, healthy weight and overweight, obese and non-obese.  An ANOVA was performed to 
assess for differences in the mean behavior, drive and severity scores between all BMI 
classifications.  Two sample t-tests were performed to assess for differences in mean 
behavior, drive and severity scores between males and females. Individuals were also 
categorized by age group and an ANOVA was performed to assess for differences in mean 
scores according to age group. Comparisons were made between responses from the non-
validated portions of the questionnaire to responses from the validated portion of the 
questionnaire.     
Fisher’s exact test allowed for the examination of the relationship between reported 
amount of food eaten and BMI classification and the relationship between reported 
increased interest in food and BMI classification.   
As the true prevalence of hyperphagia in individuals with SMS is currently unknown 
there were no definitive guidelines as to what defines hyperphagia in the SMS population.   
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RESULTS 
Part I-Characterization of Growth Patterns  
 In order to characterize the growth (height, weight and BMI) of a cohort of individuals 
with Smith-Magenis syndrome, a retrospective chart review was conducted.  In addition to the data 
collected using  the retrospective chart review, the data presented in Part I also includes the 
height, weight and corresponding BMI measurements of 25 individuals with SMS whose 
parent’s recorded their child’s height and weight on the parent questionnaire.   
When the data obtained from the chart review and questionnaire was combined, at 
least one set of growth measurements (both height and weight ascertained at the same time) 
was available for all 78 individuals with SMS.  Of the 78 total individuals, 35 were male 
(45%) and 43 were female (55%).  The number of growth measurements available for each 
individual varied from one to six sets of measurements. The majority of individuals, 51 
(61.5%), had only one or two growth measurements available.  Figure 1 provides a graphical 
representation of available growth measurements.   
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A total of 194 weight measurements were analyzed of which, 169 were obtained 
from the chart review and 25 were obtained from the questionnaire.  A total of 167 height 
measurements were analyzed, of which, 142 were obtained from the chart review and 25 
were obtained from the questionnaire. There were 167 sets of measurements that included 
both weight and height measurements.  
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Figure 1. Growth Measurements 
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Age 
The mean and median age was calculated using the individual’s age at the last 
recorded measurement.  The mean age at the final measurement was 13.7 years and the 
median age was 11.1 years for all 78 individuals.  The youngest age recorded was a birth 
measurement (age=0) and the oldest age recorded was 51 years.  Based on their age at their 
last recorded measurement, individuals were coded into age groups using the classifications 
provided by the CDC.  Table 4 provides a detailed overview of the age distribution in our 
SMS cohort.   
 
 
 
 
 
 
 
 
 
 
Growth Measurements 
The mean height and weight were calculated for the combined cohort, as well as 
separately for males and females after stratification by age group.  Table 5 summarizes the 
mean height and weight for the combined cohort.  The mean age for each age group is also 
provided.    
 
Table.  4 Age Distribution, Overall Population  
n=78 
Age Group Corresponding Age # of individuals % 
1 0-23 months 4 5% 
2 2-5 years 16 21% 
3 6-11 years 22 28% 
4 12-19 years 22 28% 
5 >20years 14 18% 
Total  78 100% 
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Both weight and its corresponding height measurement were obtained for 96 females 
in the cohort.  There were 19 females who had weight measurements but were missing the 
corresponding height measurement.  Table 6 summarizes the mean height and weight for the 
females in the cohort.  The mean age for each age group and the number of measurements 
are also provided.    
 
 
 
 
 
 
 
 
 
 
Table 5. Growth Measurements, Combined Males & Females 
 
   Mean height (cm) Mean weight (kg) 
Age 
Group 
Age  Mean Age 
(years)  
n µ SD n µ SD 
         
1 0 -23 m 0.34 24 61.5 13.3 49 4.93 2.76 
2 24 m - 5yrs 4.09 50 94.4 9.09 51 15.25 3.65 
3 6 - 11 yrs 8.60 42 120.99 14.09 42 28.47 15.06 
4 12- 19 yrs 15.79 32 151.78 11.14 33 60.75 20.77 
5 >  20 yrs 30.88 19 162.21 11.17 19 73.73 15.22 
Total   167   194   
 
Table 6. Growth Measurements, Females 
Total Number of Female Growth Measurements 
    Mean height (cm) Mean weight (kg) 
Age 
Group Age n 
Mean Age 
(years) n µ SD n µ SD 
          
1 0 -23 m 24 0.36 15 58.8 12.05 24 4.9 2.8 
2 24 m - 5yrs 28 4.12 28 92.94 8.91 28 14.9 3.84 
3 6 - 11 yrs 27 8.59 27 119.34 12.77 27 25.9 12.1 
4 12- 19 yrs 19 15.99 19 148.93 10.92 19 57.9 21.07 
5 >  20 yrs 7 32.3 7 153.14 7.17 7 68.8 14.67 
Total  105  96   105   
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Both height and weight measurements were obtained at the same time for 71 males 
in the cohort.  There were 18 males who had a weight measurement but they were missing 
the corresponding height measurement.  Table 7 summarizes the mean height and weight for 
males in the cohort.  The mean age for each age group is also provided.   
 
 
Body Mass Index (BMI) 
Body Mass Index (BMI) was calculated for all individuals greater than 24 months of 
age.  There were four individuals who were less than 24 months of age at their last recorded 
measurement; therefore BMI could not be calculated for these individuals. For individuals 
less than 20 years of age, BMI and BMI percentile for age were calculated.  The 
interpretation of BMI during childhood and adolescence is different than the interpretation 
of BMI in adulthood, thus it was necessary to calculate BMI percentile in order to interpret 
the BMI of individuals less than 20 years of age.  For individuals greater than 20 years of 
Table 7. Growth Measurements, Males 
Total Number of Male Growth Measurements 
    Mean height (cm) Mean weight (kg) 
Age 
Group 
Age  n Mean Age 
(years) 
n µ SD n µ SD 
          
1 0 -23 m 25 0.33 9 66.01 14.05 25 4.95 2.79 
2 24 m - 5yrs 23 4.06 22 96.25 9.18 23 15.68 3.43 
3 6 - 11 yrs 15 8.63 15 123.98 16.24 15 33.0 18.89 
4 12- 19 yrs 14 15.5 13 155.93 10.5 14 64.58 20.47 
5 >  20 yrs 12 30.1 12 167.5 9.66 12 76.13 15.5 
Total  89  71   89   
 
 age, BMI was calculated and interpret
interpretation of BMI in adults
Figure 2 provides a graphical representation of BMI distribution of SMS individuals 
at the last recorded measurement for 74 individuals.  
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Weight-for-age, Height-for-age and BMI-for-age Z-score calculations 
In order to interpret the meaning of the height, weight and BMI values of individuals 
with SMS, height-for-age, weight-for-age and BMI-for-age Z-scores were calculated.  The 
z-score is defined as: “the deviation of a given variable, x, from the mean divided by the 
standard deviation” (Dawson & Trapp, 2004,2001) and it indicates how different a raw 
value is from a population mean.   A negative z-score corresponds to a value less than the 
population mean and a positive z-score corresponds to a z-score greater than the mean.  For 
our analysis the population mean and standard deviation used in the calculation were based 
on the normally distributed reference standard as defined by the CDC (Statistics, N.C.f.H., 
2000).  Therefore, the calculation of z-scores is able to provide information on how the 
growth parameters of individuals with SMS compare to that of the general US population.    
For males and females age 24 months – 19 years of age the  height-for-age, weight- 
for age and BMI-for-age Z scores were calculated using the reference standard values 
corresponding to their given age and gender. For males and females >20 years of age their 
height-for-age, weight-for age and BMI-for-age Z-scores were calculated using the reference 
standard for a 19-year-old of their given gender.    
One sample t-tests were run using the calculated Z-scores for the following: height-
for-age, weight-for-age and BMI-for-age.   Table 8 provides detailed information regarding 
the mean Z-scores for males and Table 9 provides detailed information regarding the mean 
Z-scores for females, reported by age category.    
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Males-height-for age Z-scores 
For males in all age categories, the difference in height-for-age mean Z-scores 
between males at the previously described age groups and what is expected for their age was 
statistically significant (p = 0.01, <0.001, 0.03, 0.02 and 0.0065, respectively) demonstrating 
the male SMS individuals in all age categories in this cohort are shorter than the reference 
age-specific standards for the general population.  Table 8 provides detailed information 
regarding the height-for-age Z-scores for males.   
Males-weight-for age Z-scores 
For males in all age categories, the weight-for-age Z score p-values were not 
statistically significant demonstrating the weight of males in our SMS cohort did not differ 
(either higher/larger or lower/smaller) from what is expected in the general population based 
on age (p= 0.12, 0.10, 0.68, 0.22 and 0.35 respectively.)  
Males-BMI-for age Z-scores 
For all males in all age categories, the calculated mean BMI-for-age Z-scores were 
positive, demonstrating that the mean-BMI-for-age was greater than the 50th percentile.  At 
age groups 6-11years, 12-19 years and > 20 years, the difference in BMI-for-age mean Z-
scores between males of these age groups and what is expected in the similar age-specific 
general population was statistically significant (p=0.023, 0.0023 and  0.0018, respectively) 
demonstrating that the male SMS individuals in this cohort have a higher  BMI than what is 
expected for their age.   
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Females-height-for age Z-scores 
 For females of all age groups, all of the mean z-scores for height were negative 
which correspond to raw values below the age-specific 50th percentile.  This  difference in 
height-for-age mean Z-scores and what is expected for their age was statistically significant 
(p= 0.0016, <0.001, < 0.001, 0.001 and 0.009, respectively) demonstrating the female SMS 
individuals in this cohort in all age groups are significantly shorter than expected based on 
their age.    
Females-weight-for age Z-scores 
   The calculated weight-for-age mean z-scores were negative for females 0-23 
months, 24 months- 5 years and 6-11 years.  These negative z-score for females correspond 
to values less than the 50th percentile.  The difference in mean-weight-for-age Z-scores and 
what is expected based on their age was statistically significant (p= 0.0035, 0.0122 and 
0.008, respectively.), demonstrating the female SMS individuals in this cohort from the ages 
of 0-23 months, 24 months -5 years and 6-11 years, weigh less than what is expected for 
their age.   It is only in the age category of 12-19 years and ≥ 20 years that the mean weight-
for-age Z-scores are positive.  In other words, prior to age 12, female SMS individuals in 
this cohort had weight-for-age mean z-scores less than the 50th percentile and at age 12 years 
and older, female individuals with SMS in this cohort had weight-for-age mean z-score 
greater than the 50th percentile.  Although the weight-for-age mean z-scores for females 
crossed from less than the 50th percentile to greater than the 50th percentile as they aged, 
statistical significance was not achieved (p= 0.50 at 12-19 years and p= 0.192 at ≥20 years.)   
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Females BMI-for-age Z-score 
For females of all age groups, the calculated mean BMI-for-age Z-scores are 
positive, thus corresponding to BMI’s greater than the 50th percentile.  In the following age 
groups: 24 months -5 years, 12- 19 yrs  and > 20 years, the difference in BMI for age mean 
Z-scores and what is expected for their age was statistically significant (p= <0.001, 0.013 
and 0.0039, respectively) demonstrating that the female SMS individuals in these age groups 
have higher BMI than what is expected for their age.  
In summary, it appears that both males and females with SMS are shorter than their 
peers, but have average weight, thus corresponding to higher BMI’s.  Figures 3-5 provide a 
graphical representation of the mean height-for-age, weight-for age and BMI-for-age Z-
scores for males and Figures 6-8 provide a graphical representation of the mean height-for-
age, weight-for-age and BMI-for-age Z-scores for females.  
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 N µ SD p n µ SD p n µ SD p 
0 -23 m 9 -1.19 1.08 0.01 25 -0.33 1.03 0.12     
24 m - 5 yrs 22 -1.43 1.49 < 0.001 23 -0.52 1.45 0.10 22 0.59 1.48 0.074 
6 - 11 yrs 15 -1.31 2.11 0.0304 15 0.288 2.65 0.68 15 1.63 2.47 0.023 
12- 19 yrs 13 -1.50 1.39 0.0022 14 0.575 1.67 0.22 13 1.45 1.36 0.0023 
>  20 yrs 12 -1.40 1.43 0.0065 12 0.351 1.25 0.35 12 1.10 0.93 0.0018 
Total 69    89    62   
 
 
 n µ SD p n µ SD p n µ SD p 
0 -23 m 15 -1.46 1.45 0.0016 24 -0.813 1.223 0.0035     
24 m - 5 yrs 28 -2.13 1.05 <0.001 28 -0.719 1.42 0.0122 28 1.09 1.19 <0.001 
6 - 11 yrs 27 -1.99 1.12 <0.001 27 -0.842 1.51 0.008 27 0.43 1.52 0.16 
12- 19 yrs 19 -1.89 1.51 <0.001 19 0.294 1.884 0.5041 19 1.29 2.04 0.013 
>  20 yrs 7 -1.65 1.17 0.009 7 0.717 1.29 0.192 7 1.84 1.07 0.0039 
Total 96    105    89   
 
 
Table 8. Z-score for Males, by age group 
 Z score height Z score weight Z score BMI 
Table 9. Z-score for Females, by age group 
 Z score height Z score weight Z score BMI 
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Figure 3,   Two way scatter plot, Males, height-for-age 
Z-scores by age group 
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Figure 4,   Two way scatter plot, Males, weight-for-age 
Z-scores by age group 
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Figure 5.      Two way scatter plot, Males, BMI-for-age 
Z-scores by age group 
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Figure 6. Two way scatter plot, Females, height-for-age 
Z-scores by age group 
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Figure 7. Two way scatter plot, Females, weight-for-age 
Z-scores by age group 
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Figure 8. Two way scatter plot, Females, weight-for-age 
Z-scores by age group 
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Part 2- Parent Questionnaire  
 Part II of this study involved the use of a parent questionnaire to assess hyperphagia 
or related abnormal food behaviors in individuals with SMS.  The parent questionnaire was 
used to provide information on the food related behaviors that may be related to overweight 
and obesity among individuals with SMS.  
Demographics 
A total of 25 questionnaires were completed by parents of children and adults with 
Smith-Magenis syndrome.  All of the participants who completed the questionnaire were 
ascertained through a database of SMS patients maintained by Baylor College of Medicine 
(BCM) at Texas Children’s Hospital.  Twenty-five completed questionnaires were received 
out of the 89 total questionnaires mailed, corresponding to a response rate of 28.1%. 
Demographic information was available for 24 of 25 questionnaires as one individual did 
not complete the demographic portion of the questionnaire.  Not all participants answered all 
questions within the demographic portion of the questionnaire.   
Twenty out of twenty five participants correctly reported their age on the 
questionnaire.  There was one individual who did not respond to any question on the 
demographic section of the questionnaire, and four individuals who listed their child’s age 
and not their own age. Of the twenty participants who correctly indicated their age on the 
questionnaire, the average age of the participants was 50.3 years with a range of 34 years to 
75 years.  The majority of the participants were Caucasian (n=19; 79.17%) with English 
being the primary language (n=21; 87.50%).  Other languages included Spanish (n=2; 
8.33%) and Chinese (n=1; 4.17%).  The majority of participants reported they were married 
or living as married (n=21; 87.5%).  One participant (4.17%) indicated they were separated 
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and two individuals (8.33%) indicated they were divorced.  None of the participants 
identified themselves as single.  The majority of participants (n=13; 54.16%) indicated they 
had a Bachelor’s degree or an advanced education degree. The lowest level of education was 
9th to 11th grade in one individual (4.17%).  Seventy nine percent (n=19) of the 
questionnaires were filled out by mothers, with fathers completing 16.67% (n=4). One 
questionnaire was completed by an adoptive parent.   The majority of participants (n=15; 
62.5%) were employed.  The average yearly income ranged from less than $25,000 (n=1; 
4.35%) to greater than $100,000 (n=10; 43.48%).  There were two individuals who preferred 
not to provide their average income and either indicated “prefer not to answer” or left the 
question blank.  Table 10 provides detailed information on the demographics of the 
participants (parents/caregivers).  
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Table 10. Demographics of Participants(Parents)  
Completed Questionnaire  
 
Number % 
 
 
Number     % 
Total Participants 
(N) 
25 28.1% Marital Status   
   Married/Living as married 21 87.5% 
Age   Separated 1 4.17% 
34-44 6 30% Divorced 2 8.33% 
45-54 9 45% 
 
24  
55+ 5 25% Employment Status    
 20  Yes, Employed 15 62.5% 
Ethnicity   No, Not Employed  9 37.5% 
White 19 79.2%  24  
Hispanic  4 16.7% Annual Income   
Asian 1 4.17% Less than $25,000 1 4.2 % 
 24  $25-50,999 6 25% 
Primary Language   $21-74,999 2 8.15% 
English 21 87.5% $75-99,999 3 12.5% 
Spanish  2 8.33% $100,000 or more 10 42% 
Other (Chinese) 1 4.17% Prefer not to answer/left 
blank 
2 8.15% 
 24   24  
Relationship to child 
with SMS 
  Highest Education Level   
Mother 19 79.2% 9th to 11th grade 1 4.17% 
Father 4 16.7% High School or GED 3 12.5% 
Other (adoptive 
mother)  
1 4.2% Some college 6 25.0% 
 24  Associates Degree 1 4.17% 
 
  Bachelor’s Degree 5 20.8% 
 
  Advanced Degree 8 33.3% 
 
   24  
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Demographics of SMS individuals 
Demographic information was available for 25 individuals with SMS.  Nine individuals 
(36%) were male and 16 individuals (64%) were female. The median age of individuals with SMS in 
this study was 20 years with a range of 8 years of age to 51 years of age.  Thirteen individuals (52%) 
were greater than 20 years of age.  Individuals were categorized by age using the classifications 
provided by the CDC.  Table 11 provides information on the age distribution of SMS individuals.  
 
 
 
 
 
 
 
Child’s Medical History 
The average age at diagnosis was 8.65 years of age with a range of 1 month of age to 
30 years of age, with most individuals (n=12; 48%) diagnosed prior to five years of age.   
The majority of parent’s (n=17; 68%) reported their child was diagnosed by a geneticist and 
most had a 17p11.2 deletion (n=22; 88%). One parent reported their child had a RAI1 
mutation, while two parents reported they were unsure of the genetic etiology of SMS in 
their child.  Seven out of twenty four parents (28%) reported their child had been diagnosed 
Table 11.  Age Distribution of SMS individuals  
 
Age Group Corresponding Age # % 
1 0-23 months 0 0 
2 2-5 years 0 0 
3 6-11 years 3 12% 
4 12-19 years 9 36% 
5 >20years 13 52% 
  25 100% 
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with failure to thrive (FTT).  Two parents (8%) reported their child needed a feeding tube; 
neither reporting surgical placement of the feeding tube.    
Regarding congenital anomalies, the most common congenital anomaly reported by 
parents was heart defect; eight parents (32%) reported their child had been diagnosed with a 
heart defect.  One parent reported their child was diagnosed with a cleft lip (4%), four 
parents reported their child was diagnosed with a cleft palate (16%), two parents reported 
their child was diagnosed with a kidney defect (8%), four parents reported their child was 
diagnosed with a urinary tract defect (16%) and five parents reported their child was 
diagnosed with low thyroid function (20%).  Table 12 provides a detailed overview of the 
medical history data as reported by parents completing the questionnaire.   
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Table. 12 Medical History of SMS Individuals 
(as reported by parent on questionnaire)  
 # %   # % 
Age Diagnosed  
  
Diagnosed Cleft Lip 
  
Birth- 5 years 12 48% Yes 1 4% 
6-10 years 6 24% No 24 96% 
11-20 years 4 16%    
21+ years 3 12% Diagnosed Cleft Palate    
   
Yes 4 16% 
Diagnosis Made By  
  
No 21 84% 
Pediatrician 1 4%    
Geneticist 17 68% Diagnosed Heart Defect    
Neurologist 1 4% Yes 8 32% 
Developmental Specialist  4 16% No 17 68% 
Other  2 8%    
 
  
Diagnosed Kidney Defect  
  
Genetic Etiology 
  
Yes 2 8% 
17p11.2 deletion 22 88% No 23 92% 
RAI1 mutation  1 4%    
Don’t know 2 8% 
Diagnosed Urinary Tract 
Defect    
   Yes 4 16% 
Diagnosis of Failure to Thrive 
(FTT)   
No 
21 84% 
Yes 17 68%    
No 
7 28% 
Diagnosed Low Thyroid 
Function     
Don’t know 1 4% Yes 5 20% 
   No 20 80% 
Feeding Tube Placed 
  
  
Yes 2 8% 
No  23 92%  
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Child’s Medication History  
Parents were asked if their children had ever taken medication for any of the 
following: heart defects, seizures, diabetes, high cholesterol, high blood pressure, thyroid 
problems, kidney problems, acid reflux, kidney reflux, anxiety, depression, 
hyperactivity/ADD, sleep disturbances, self-injurious behavior, aggression or obsessive 
compulsive behaviors.  Twenty respondents, (83.33%), reported their child had been 
prescribed medication for sleep disturbances. Sixteen parents (69%) reported their children 
had been prescribed medication for anxiety and fourteen, (58.33%) reported their children 
had been prescribed medication for hyperactivity/ADD. Table 13 provides a detailed 
overview of the medication history reported by the participants regarding their children with 
SMS.   
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Table 13. Medication History of Individuals with SMS as Reported by Participating Parent 
 
 Number %  Number % 
Heart Defect   Acid Reflux   
Yes 1 4.55% Yes 8 65.22% 
No 21 95.45% No 15 34.78% 
      
Seizures   Anxiety   
Yes 5 21.74% Yes 16 69.57% 
No 18 21.74% No 7 30.43% 
      
Diabetes   Depression   
Yes 3 13.64% Yes 6 26.09% 
No 19 86.36% No 17 73.91% 
      
High Cholesterol   Hyperactivity/ADD   
Yes 4 18.18% Yes 14 58.33% 
No 18 81.82% No 10 41.67% 
      
High Blood Pressure   Sleep Disturbances   
Yes 1 4.55% Yes 20 83.33% 
No 21 95.45% No 4 16.67% 
      
Abnormal Thyroid    Self Injurious Behavior   
Yes 4 18.18% Yes 11 50% 
No 18 81.82% No 11 50% 
      
Abnormal Kidney 
Function    
Obsessive Compulsive 
Behaviors   
Yes 1 4.55% Yes 11 50% 
No 21 95.45% No 11 50 
      
Kidney Reflux   Aggression   
Yes 2 9.09% Yes 11 47.83% 
No  20 90.91 No 12 47.83% 
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Parents were also asked if any of the medications taken by their child had affected 
their appetite, weight or activity level.  Nine parents listed at one least medication; however 
only seven parents indicated the name of the medication as well as effect of the drug.  
Among the nine parents who reported any medication use in their child, the most commonly 
reported medication was Risperdal (n=5).  Of interest is that the most commonly used drug 
(Risperdal), as well as other drugs (Thorazine, Serequel, Fluoxamine), were reported to 
result in increased weight and/or increased appetite. Table 14 summarizes the limited 
information obtained regarding medication history and effect of appetite, weight or activity 
level. 
 
 
 
 
 
 
To further investigate if a medication may have caused a change in behavior or 
weight in a child, the corresponding BMI of the child was examined.  Of those who reported 
that a medication increased their child’s weight or appetite levels (n= 6), one individual had 
a BMI in the healthy range, 2 had an overweight BMI and three had an obese BMI.  Of those 
who listed a medication but did not report the effect (n=2), both individuals had a healthy 
BMI.  Of those individuals who did not respond to the question, eight were classified as 
Table 14. Medications Prescribed 
Rx Name #  Possible Effects 
Risperdal 5 INCREASED(NOTHING SPECIFIED); INCREASE 
WEIGHT;INCREASE WEIGHT, INCREASE APPETITE 
Topamax 1  
Ritalin 3 DECREASE (NOTHING SPECIFIED); DECREASE WEIGHT, 
DECREASE APPETITE, INCREASE PHYSICAL ACTIVITY 
Thorazine 1 INCREASE WEIGHT, INCREASE APPETIE, DECREASE 
PHYSICAL ACTIVITY 
Serequel 1 INCREASE WEIGHT, INCREASE APPETITE 
Fluoxamine 1 INCREASE WEIGHT, INCREASE APPETITE 
Adderall 1  
Abilify 1  
Inprimine 1  
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healthy BMI, four were classified as overweight BMI and four were classified as obese 
BMI.  One parent reported a medication (Ritalin) decreased her child’s weight; this 
individual had an obese BMI.   
Family History Information  
To assess for additional factors that could affect a child’s weight, and in turn BMI 
and overall health status, parents were asked whether or not there was a family history of 
any of the following: overweight, obesity, hypertension, diabetes, pre-diabetes, high 
cholesterol and heart disease.  Table 15 provides family history information.   
  
 
 
 
 
 
 
 
 
 
 
Table 15. Family History 
 Number % 
Overweight   
Yes 9 36% 
Missing 16 64% 
   
Obesity   
Yes 7 28% 
Missing 18 72% 
   
Hypertension   
Yes 11 44% 
Missing 14 56% 
   
Diabetes   
Yes 10 40% 
Missing 15 60% 
   
Pre-Diabetes   
Yes 5 20% 
Missing 20 80% 
   
High-Cholesterol   
Yes 12 48% 
Missing 13 52% 
   
Heart Disease   
Yes 5 20% 
Missing  20 80% 
50 
 
Child’s Social and Education History 
 Sixteen out of twenty-four (66.67%) of parent’s indicated their children lived at home, with 
seven (29.17%) parents indicating their child lived in a group home/assisted living facility.  One 
parent (4.16%) indicated her child lived in her own home with 24-hour support staff.   
Parents were also asked “what was the highest level of schooling your child has completed?” 
Figure 9 summarizes the responses regarding the child’s education.   
 
 
 
 
 
  
 
 
 
 
 
 
 
 
No 
Response
2
8%
Did not attend 
school
1
4%
Currently in 
Elementary 
School
3
12%
Did not finish 
Elementary 
School
1
4%Middle School
4
16%
High School-
Not Specified
11
44%
Currenly in 
High School
1
4%
High School-
Special 
Diploma
2
8%
Figure 9. Distribution of education
in SMS individuals
N=25 
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Child’s Exercise History 
Twelve parents, 48%, reported their child had a regular exercise program.  Of those parent’s 
who reported their child was able to exercise but that their child did not have a routine, the most 
common response provided as to why those children did not exercise was “will not participate in 
physical activity.” 
Dietary History   
On the questionnaire that was created for use this study, there were ten questions targeted to 
assess the dietary history of SMS individuals. Parents were asked if they felt their child had daily 
eating patterns similar to other children his or her age.  Fifteen parents answered Yes (60%) and 10 
parents answered No (40%).  All parents (N=25; 100%) indicated their children ate breakfast, lunch, 
dinner and snacks each day.  Fifty-two percent of parents (n=13) indicated their child snacked prior 
to bed time.   
Parents were asked to list their child’s top three favorite snacks.  Because of the variable 
responses provided, categorizations of snacks were created for better analysis.   After all of the 
questionnaires were received, the responses to this question were looked at as a whole and 
categorizations were created for the snack items listed.  The snack categories were: “healthy”, which 
included items such as fruits and vegetables; “non-healthy”, which included items such as cookies, 
chips and cakes and a third “other” category which included foods such as pretzels, popcorn and 
pudding.  Based on these snack classifications, 18 out of 25 parents (72%) indicated their child’s 
favorite snack was an item classified under the “non-healthy” item, 2 out 25 (8%) indicated their 
child’s favorite snack was in the “other” category and 5 out of 25 parents indicated their child’s 
favorite snack was an item classified as “healthy.”    
Parents were also asked to categorize the amount of food their child ate.  Six parents (25%) 
indicated they felt their child ate less than normal amounts of food, eight parents (33.33%) indicated 
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they felt their child ate normal amounts of food and ten parents (41.67%) indicated they felt their 
child ate greater than normal amounts of food.  Parents were asked if their child binge ate; 50% 
indicated Yes and 50% indicated No.   
As individuals with SMS have disruptive sleep patterns, it was important to assess the 
presence of this finding within our questionnaire as well as to investigate whether individuals with 
SMS were also participating in night-time food seeking which may be considered an abnormal food 
seeking behavior.  The majority of parents (n=12;48%) indicated their child woke up 2-3 times per 
night, with 13.64% (n=3) of parent’s indicating their child woke up greater than or equal to four 
times each night.   
Parents also reported, of the times their child woke per night, how often they ate.  Twelve 
parents (48%) indicated never, two (8%) indicated rarely, three (12%) indicated occasionally and 
five (20%) indicated always (Figure 10).   Three parents hand wrote on their questionnaire that their 
child does not participate in night-time food seeking because the food is now locked. This response 
was interpreted to mean night-time food seeking is currently not a problem for these three SMS 
individuals because the food is now locked and they are unable to access it.  A separate category was 
created for those individuals(12%) who indicated their child no longer participated in night-time 
food seeking, as the food is now locked.   
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The majority of parents, (nineteen; 76%) indicated they have to lock food away from their 
child.  Of those six parents who indicated they did not lock food from their child, one parent reported 
they try not to have tempting food in the house, but they don’t lock the food.    
 
Growth Measurements of individuals with SMS as reported by their Parents 
In order to obtain the most recent growth parameters for the SMS individuals whose parents 
completed the mail out questionnaire, parents were asked to provide their child’s current height and 
weight.   Growth parameters were reported by parents in all 25 responses.  The average height for the 
cohort was 153.6 cm and the average weight was 65.2 kg.  For males, (n=9) the average height was 
167.67 cm, the average weight was 73.9 kg and the average BMI was 26.2. For females, (n=16) the 
average height was 145.71 cm the average weight was 60.4 kg and the average BMI was 27.73. 
Tables 16-18 provide an overview of growth parameters in the cohort.    
 
Never
n= 12
48%
Rarely
n=2
8%
Occasionally
n=3
12%
Always
n= 5
20%
Food Locked
n= 3
12%
Figure 10. Distribution of children 
participating in night-time food seeking
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Table 16. Growth Measurements, All individuals,  
N=25 
  Height (cm) Weight (kg) BMI 
 N µ SD Min Max µ SD Min Max µ SD Min Max 
 25 153.6 18.64 91.4 183 65.2 20.32 23 100 27.17 5.55 16.89 38.95 
 
Table 17. Growth Measurements, Males 
n=9 
  Height (cm) Weight (kg) BMI 
 n µ SD Min Max µ SD Min Max µ SD Min Max 
6-11yrs 0             
12-19yrs 1 163 ---- ---- ---- 55 ---- ---- ---- 20.7 ---- ---- ---- 
>  20yrs 8 168.13 9.46 155 183 76.2 14.62 60 100 26.8 3.52 22.6 30.78 
              
Total  9 167.6 9.011 155 183 73.9 15.4 55 100 26.2 3.88 20.7 30.78 
 
Table 18. Growth Measurements, Females 
n=16 
  Height (cm) Weight (kg) BMI 
 n µ SD Min Max µ SD Min Max µ SD Min Max 
6-11yrs 3 115.5 21.13 91.4 131 28.3 5.03 23 33 21.82 5.1 16.9 27.1 
12-19yrs 8 152.9 8.76 135 163 67.6 19.14 39 90 28.9 6.9 21.4 38.9 
>  20yrs 5 152.4 5.77 145 160 68 11.78 52 79 29.3 4.8 24.2 35.1 
              
Total  16 145.71 18.15 91.4 163 60.4 21.55 23 90 27.73 6.35 16.9 39 
 
 
 
55 
 
BMI and BMI percentile in individuals < 20 years 
For individuals less than 20 years of age BMI and BMI percentile were calculated.  BMI 
percentile provides information regarding a given child’s BMI in comparison to that of other 
children his or her own age and gender.  There were eleven females and one male less than 20 years 
of age, to give a total of twelve individuals for which the BMI percent was calculated. As there was 
only one male, limited statistically analysis could be performed regarding BMI in males less than 20 
years of age.  For females less than 20 years of age, the average BMI was 27.04 and the average BMI 
percent was 78.1, which is considered “healthy”.  Table 19 provides detailed information on the BMI 
of individuals less than 20 years of age.  
Table 19. BMI and BMI% in individuals < 20 years of age 
n=12 
 BMI BMI percentile  
 n µ SD Min Max n µ SD Min Max 
 
          
Males 1 20.7 - - - 1 29 - - - 
Females 11 27.04 7.03 16.9 39 11 78.1 25.6 23.1 98 
 
          
All 12 26.5 6.9 16.9 39 12 74.0 28.2 23.1 98 
 
Figure 11 illustrates the distribution of BMI classifications in individuals less than 20 years 
of age, based off BMI%.  
 
 
 
 
 
 
 
Healthy 
weight
n= 6
50%Overweight
n= 1
8%
Obese 
n= 5
42%
Figure 11. BMI, Individuals < 20 years of age, 
n=12
Weight Category BMI % 
Underweight BMI  <5th  
Healthy weight 5th ≤ BMI <85th 
Overweight 
85th ≤ BMI < 
95th 
Obese BMI ≥95th 
 
 BMI in individuals ≥ 20 years 
There were 13 individuals greater than 20 years of age, for which BMI was calculated and 
interpreted using the CDC’s recommendation for the interpretation of BMI in adults. The average 
BMI for individuals > 20 years of age was
(38.46%) were classified as healthy weight, 5 individuals (38.46%) were classified as overweight 
and 3 individuals (23.08%) were classified as obese, corresponding to 61.54% of all individuals 
greater than 20 years of age being either overweight or obese.  There were no individuals classified 
as underweight.  Figure 12 illustrates the BMI classifications in individuals greater than 20 years of 
age.   
 
 
 
 
 
 
 
 
Calculation of BMI% in individuals < 20 
20 years of age allowed for the examination of BMI in all individuals combined.  When analyzing 
BMI classifications for all individuals (N=25), 11 (44%) were classified as healthy weight, 6 (24%) 
were classified as overweight and 8 (32%) were classified as obese.  Thus 56% of individuals in the 
Overweight
n= 5
38%
Obese
n= 3
23%
Figure 12. BMI, Individuals 
 27.8.  Based on these classifications, 5 individuals 
years of age and BMI in individuals greater than 
Healthy weight
n= 5
39%
≥ 20 years of age
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combined cohort have an overweight or obese BMI.  There were no individuals classified as 
underweight.  Figure 13 provides an illustration of BMI classifications in all individuals.     
 
Z-scores 
It was necessary to calculate the Z-score for height-for-age, weight-for-age and BMI-for-age 
to allow for comparison between the reference standard as defined by the CDC and the SMS cohorts.  
One sample t-tests were run using the calculated Z-scores for the following: height-for-age, weight-
for-age and BMI-for-age.   The negative mean Z-score for height (µ = -1.72) demonstrates this 
cohort of SMS individuals were significantly shorter for their age (p= 0.001).  The mean weight-for-
age Z-scores for the combined cohort, were not statistically significant (p-value = 0.062), 
demonstrating the weight for age Z-scores in the SMS individuals were not statistically different 
(either higher/larger or lower/smaller) from age matched standardized controls in the general 
population.  Despite non-significant weight-for-age mean Z-scores, the positive mean Z-score for 
BMI for age (µ = 1.59) demonstrates the SMS individuals have significantly higher BMI’s for age (p 
<0.001). Table 20 provides detailed information regarding the mean Z-scores for all individuals for 
height, weight and BMI.   
Healthy weight
n=11
44%
Overweight
n=6
24%
Obese 
n=8
32%
Figure 13. BMI, All Individuals, 
N=25
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µ SD p µ SD p µ SD p 
-1.72 1.8 0.0001 0.513 1.3 0.062 1.59 1.24 <0.001 
         
 
Z-score comparisons by Gender 
The height-for-age Z scores, weight-for-age Z scores BMI-for-age Z-scores were examined 
separately for males and females.   One sample t-tests were also run separately for males and females 
and by age groups to assess for differences within these categories.  For males, (n=9), their height-
for-age Z score and weight-for-age Z score were not statistically significant demonstrating the height 
and weight in the male SMS cohort did not differ (either higher/larger or lower/smaller) from what is 
expected for their age (p=0.052 and p=0.21 respectively). However, the difference in BMI for age 
mean Z-scores between SMS males and age appropriate controls was statistically significant, 
demonstrating male SMS individuals have higher average BMI for age.  (p=0.01) Table 21 provides 
a detailed overview of Z-score values in males. 
 
µ SD p µ SD p µ SD p 
-1.02 1.34 0.052 0.46 1.02 0.21 1.06 0.95 0.01 
         
 
For females, n=16, their weight for age mean Z-score was not statistically significant 
demonstrating the mean weight-for-age in the female SMS cohort did not differ from what is seen in 
the general population (p=0.16).   The mean Z-score for height (µ= -2.12) demonstrated the females 
in our population were significantly shorter for their age (p= 0.006).  The difference in BMI-for-age 
Table 20.  Z-scores for All individuals 
 N=25 
Z score height Z score weight Z score BMI 
Table 21.  Z-score for Males,  
n=9 
Z score height Z score weight Z score BMI 
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mean Z-scores between all females and what is expected for their age was statistically significant (p< 
0.001) demonstrating female SMS individuals have higher BMI for age than what is expected.   
Table 22 provides a detail overview of Z-score values in females.   
µ SD p µ SD p µ SD p 
-2.12 1.94 0.006 0.54 1.48 0.16 1.89 1.31 < 0.001 
         
 
Z-score comparisons by Age & Gender 
 We also examined the Z-scores for height-for-age, weight-for-age and BMI-for-age by fist 
subdividing by gender and then by age.   For males, the only Z-score p-value that reached statistical  
significance was the BMI-for-age Z-score for males  > 20 years of age, demonstrating that males > 
20 years of age had larger BMI’s than what was expected for their age (p= 0.005).  Table 23 provides 
a detailed overview of Z-scores for males, by age group.   
 n µ SD p µ SD p µ SD p 
6 - 11 yrs 0 0 0 0 0 0 0 0 0 0 
12- 19 yrs 1 -0.15 - - -0.407 - - -0.34 - - 
>  20 yrs 8 -1.12 1.39 0.055 0.57 1.034 0.163 1.23 0.8514 0.005 
 
          
Total, All 
Males  
9 -1.02 1.34 0.052 0.46 1.02 0.21 1.06 0.95 0.01 
 
 
For females, n=16, there were several Z-score p-values that reached statistical significance. 
For females 12-19 years of age, their height-for-age Z score and BMI-for-age Z score p-values were 
both statistically significant (p= 0.007 and p=0.01 respectively), demonstrating females age 12-19 
Table 22. Z-scores for Females,  
n=16 
Z score height Z score weight Z score BMI 
Table 23. Z-score for Males, by Age Group 
 Z score height Z score weight Z score BMI 
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years of age were significantly shorter and had larger BMI’s than what was expected based on their 
age. For females  > 20 years of age their height-for-age Z score and BMI-for-age Z score p-values 
were both statistically significant (p= 0.01 and p=0.019 respectively), demonstrating females  > 20 
years of age were significantly shorter and had larger BMI’s than what was expected based on their 
age. Table 24 provides a detailed overview of Z-scores for females, by age group.   
 n µ SD p µ SD p µ SD p 
6 - 11 yrs 3 -3.6 4.06 0.26 -0.59 1.54 0.58 1.89 2.05 0.251 
12- 19 yrs 8 -1.7 1.3 0.007 0.92 1.64 0.16 1.89 1.35 0.0053 
>  20 yrs 5 -1.83 0.89 0.01 0.62 1.06 0.26 1.88 1.1 0.019 
 
          
Total 16 -2.12 1.94 0.006 0.54 1.48 0.16 1.89 1.31 < 0.001 
 
 
 
 
 
 
 
 
 
 
 
Table 24. Z-scores for Females, by Age Group 
 Z score height Z score weight Z score BMI 
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Hyperphagia Questionnaire  
The HQ was scored and analyzed using the methods described by Dykens et al., 2007.   
Through the use of the HQ in the PWS population, three factors, also known as subscales, emerged 
that accounted for 57% of the variance within hyperphagia.  These subscales were: behavior, drive 
and severity.  Eleven of thirteen questions on the HQ corresponded to one of these three subscales.  
Question 12 and question 13 did not correspond to any of the three subscales and were therefore 
considered separately.  Means scores were calculated for each question in the HQ. Mean scores for 
the behavior, drive and severity subscales were also calculated.  Comparisons of overall scores as 
well as mean scores for each subscale were made.   
Questions on the HQ were scored based on a Likert scale of 1 to 5, with a score of 1= not a 
problem and a score of 5= a severe and/or frequent problem.   The results to the questions are 
grouped by the corresponding subscale.  Higher scores on the HQ indicate higher levels of 
hyperphagia.  The overall behavior, overall drive and overall severity scores for each individual are 
the sum of the scores for each question within its given subscale.  For example  if everyone had 
answered every question within the hyperphagic behavior subscale with a 5, indicating the highest 
level of severity, the overall hyperphagic behavior score would be equal to 25 (there are five 
questions within hyperphagic behavior; 5 questions multiplied by a score of 5 would give a totals 
score equal to 25.) In the same respect if everyone had answered every question within the 
hyperphagic behavior subscale with a 1 indicating the lowest level of hyperphagic severity, the mean 
hyperphagic behavior scale would be equal to 5.   These overall subscale scores for all individuals 
were used to calculate the mean subscale score for our cohort. Table 25 provides the mean scores for 
all 25 individuals who completed the HQ.   
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Item 12 on the HQ asked: “at what age did you child first show an increased interest 
in food?” 18 out of 25 parents (72%) reported their child did have an increased interest in 
food.  Of those 18 parents who reported their child had an increased interest in food, the 
mean age of onset was 8.22 years.   
 
Table 25.  Hyperphagia Questionnaire Results, Mean Scores,  
All Individuals, N=25 
Question # N* Mean 
Score 
SD Min  Max 
 
     
Behavior      
10 25 3.08 1.32 1 5 
2 23 2.52 1.5 1 5 
8 22 2.45 1.5 1 5 
5 23 2.48 1.7 1 5 
4 25 1.28 0.74 1 4 
Mean Behavior 20 11.45 4.96 5 22 
 
    
Drive     
1 25 3.04 1.17 1 5 
3 25 2.8 1.04 1 5 
6 25 3.12 1.09 1 5 
9 24 2.38 1.05 1 5 
Mean Drive 24 11.3 3.71 4 20 
 
    
Severity     
7 24 2.54 1.32 1 5 
11 25 1.96 0.68 1 4 
Mean Severity 24 4.54 1.77 2 9 
* At least one question was left unanswered within the behavior, drive and 
severity subscales by 5, 1 and 1 individuals, respectively.  Scores from these 
individuals were not used in the subscale mean score calculations. 
63 
 
Comparison of HQ Scores by BMI 
We also looked at the overall hyperphagia mean scores within the different BMI 
classifications.  Table 26 summarizes the overall hyperphagia mean scores for each question on the 
HQ across the different BMI classifications; normal weight, overweight and obese weight.  The 
results are grouped by factor and items 12 and 13 were the questions that did not load onto any factor 
and are therefore considered separately from the other three factors.   
Interestingly individuals with an obese BMI tended to have higher behavior and drive scores 
but lower severity scores.   
Table 26, Overall Mean Scores, by BMI Classification 
 
Question # Healthy Weight Overweight Obese 
 
   
Behavior 11.56 8 12.63 
10 3.36 2.33 3.25 
2 2.8 2.2 2.38 
8 2.6 1.75 2.63 
5 2.5 1.6 3 
4 1.36 1 1.38 
 
  
Drive 11.9 8.83 12.38 
1 3 2.17 3.75 
3 3 2.17 3 
6 3.45 2.5 3.125 
9 2.5 2 2.5 
 
  
Severity 5.1 3.67 4.5 
7 2.9 1.17 2.75 
11 3.36 2 1.75 
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T-tests were performed to look for statistically significant differences between the mean HQ 
scores between individuals who were healthy weight and obese weight.  Although the mean behavior 
and drive scores were higher in individuals with obese BMI than in individuals with healthy BMI, 
none of these values reached statistical significance (p-values = 0.68 and 0.79, respectively.)  Table 
27 provides detailed information regarding the mean behavior, drive and severity scores in 
individuals with healthy and obese weight.   
Table 27. Mean Hyperphagic Behavior Drive and Severity scores,  
Healthy weight vs. obese weight 
Hyperphagic factors  Healthy Weight  Obese   
 n Mean SD n Mean SD p-value 
Behavior 9 11.55 5.53 8 12.625 4.75 0.68 
Drive 10 11.9 4.04 8 12.375 3.42 0.79 
Severity 10 5.1 2.02 8 4.5 1.69 0.51 
 
Furthermore, comparisons were made between the mean HQ scores of individuals who were 
overweight and those who were obese.  Although the mean behavior, drive and severity scores were 
higher in individuals with obese BMI than in individuals with overweight BMI, none of these values 
reached statistical significance (p-values = 0.16, 0.06, and 0.33 respectively.)  However, the mean 
drive scores were approaching statistical significance in obese individuals.  Table 28 provides 
detailed information regarding the mean behavior, drive and severity scores in overweight and obese 
individuals.   
Table 28. Mean Hyperphagic Behavior Drive and Severity scores,  
Overweight vs. Obese weight 
Hyperphagic factors  Overweight  Obese 
 n Mean SD n Mean SD p-value 
Behavior 3 8 3 8 12.63 4.75 0.16 
Drive 6 8.83 2.78 8 12.4 3.42 0.06 
Severity 6 3.67 1.211 8 4.5 1.69 0.33 
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Two sample t-tests were also calculated to look for differences between the mean HQ scores 
between individuals who were healthy weight and overweight.  Although the mean behavior, drive 
and severity scores were higher in individuals with healthy BMI than in individuals with overweight 
BMI, there were not statistically different, suggesting increasing BMI is not associated with higher 
mean scores on the HQ.  Table 29 provides detailed information regarding the mean behavior, drive 
and severity scores in healthy and overweight individuals.  
Table 29.  Mean Hyperphagic Behavior Drive and Severity scores,  
Healthy weight vs. Overweight 
Hyperphagic factors  Healthy weight (2) Overweight (3) 
 N Mean SD N Mean SD p-value 
Behavior 9 11.55 5.53 3 8 3 0.32 
Drive 10 11.9 4.04 6 8.83 2.79 0.13 
Severity 10 5.1 2.02 6 3.67 1.21 0.14 
 
Finally the data was reclassified and an analysis was also run comparing obese and non-
obese individuals (the latter group including both health and overweight individuals).   Although the 
mean behavior, drive and severity scores were higher in individuals with an obese BMI than in 
individuals with a non-obese BMI, none of these values reached statistical significance (p-values = 
0.40, 0.32, and 0.94 respectively) indicating that there was no statistically significant difference 
between the mean behavior, drive and severity scores between individuals who are obese and those 
who are not obese.   Table 30 provides detailed information regarding the mean behavior, drive and 
severity scores in healthy and overweight individuals. 
Table 30. Mean Hyperphagic Behavior, Drive and Severity scores,  
Obese vs. non-obese 
Hyperphagic factors  Obese  Non-obese 
 n Mean SD n Mean SD p-value 
Behavior 8 12.63 4.75 12 10.67 5.14 0.40 
Drive 8 12.38 3.42 16 10.75 3.84 0.32 
Severity 8 4.5 1.69 16 4.56 1.86 0.94 
 
  
66 
 
 
An ANOVA test was performed to assess for differences in the mean behavior, drive and 
severity scores between all BMI classifications.  No significant differences were detected (p-values = 
0.41, 0.17 and 0.30 respectively).  No association between BMI and hyperphagic subscales was 
found in this data set.  Table 31 provides detailed information regarding the mean behavior, drive 
and severity scores in healthy and overweight individuals. 
Table 31. Comparison of Mean Hyperphagic Behavior, Drive and Severity 
scores, by BMI Classification 
Hyperphagic factors  
 BMI 
Classification  N Mean SD p-value 
Behavior      
      
 Healthy 9 11.56 5.53 
0.41  Overweight 3 8 3 
 Obese 8 12.65 4.75 
  20    
Drive      
 Healthy 10 11.9 4.04 
0.17  Overweight 6 8.83 2.79 
 Obese 8 12.4 3.42 
  24    
Severity      
 Healthy 10 5.1 2.02 
0.30  Overweight 6 3.67 1.21 
 Obese 8 4.5 1.69 
  24    
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Comparison by Gender 
Two sample t-tests were run to assess for differences in mean behavior, drive and severity 
scores between males and females.  Although females had higher mean scores for all three factors, 
behavior, drive and severity, only the mean severity score was statistically significant (p-value= 
0.038) suggesting that females with SMS may have higher levels of hyperphagic severity.  Table 31 
provides detailed information regarding the mean behavior, drive and severity scores in healthy and 
overweight individuals.  
Table 32.  Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by 
Gender 
Hyperphagic factors  
 Gender N Mean SD p-value 
Behavior      
 Male 6 10 3.9 0.407 
 Female 14 12.07 3.4 
  20    
Drive      
 Male 8 9.5 3.38 0.095 
 Female 16 12.19 3.63 
  24    
Severity      
 Male 8 3.5 1.20 0.038 
 Female 16 5.06 1.80 
  24    
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Comparison by Age 
A series of ANOVAs were used to assess for difference in mean behavior, drive and severity 
scores among different age classifications of SMS individuals.  Individuals were classified by age 
group and ANOVAs were used to assess for differences.   Although not statistically significant, the 
mean behavior, drive and severity scores increased with increasing age, suggesting that there may be 
a relationship between age and hyperphagic severity.  The mean behavior, drive and severity score p-
values were 0.11, 0.52 and 0.71 respectively.   Table 33 provides detailed information regarding the 
mean behavior, drive and severity scores in healthy and overweight individuals.  
Table 33. Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by 
Age Group 
Hyperphagic factors  
 Age  
Group  N Mean SD p-value 
Behavior      
 6-11yrs 3 8 1.73 
0.11  12-19yrs 9 10.2 3.83 
 >20yrs 8 14.13 5.82 
Drive      
 6-11yrs 3 10 3.46 
0.52  12-19yrs 9 10.5 2.79 
 >20yrs 12 12.16 4.39 
Severity      
 6-11yrs 3 4 1.73 
0.71  12-19yrs 9 4.33 1.802 
 >20yrs 12 4.83 1.85 
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Comparison by Age and Gender 
 Due to differences between gender and age distribution within our study population 
(Table 34), data for behavior, drive and severity scores were reanalyzed after adjusting age 
and gender for each other.  Stratification by gender showed that among females, behavior 
scores were highest in the oldest age group (p=0.0018) (Table 34).  In addition, among 
females, although there were trends of higher scores by increasing age, there were no 
statistically significant differences between the different age groups for drive (p=0.063) or 
severity (p=0.115) scores.  Among males, there were no statistically significant differences 
in behavior (p=0.460), drive (p=0.302) or severity (p=0.200) scores between the different 
age groups. 
 
 
 
 
Comparison of scores for males and females was also performed after stratification 
by age group.  The only statistically significant difference was in the oldest age group, 
where females had higher scores than males for behavior (p=0.010), drive (p=0.035) and 
severity (p=0.005) (Table 35) 
 
 
 
 
Table 34. Distribution of Gender by Age Groups 
 
 Males Females Total 
6-11yrs 0 3 3 
12-19yrs 1 8 9 
≥ 20 yrs 8 5 13 
Total 9 16 25 
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Table 35.  Comparison of Mean Hyperphagic Behavior, Drive and Severity scores by Age 
Group and Gender 
  Males Females 
  n Mean SD n Mean SD 
6-11yrs Behavior    3 8.00 1.73 
 Drive    3 10.00 3.46 
 Severity    3 4.00 1.73 
        
12-19yrs Behavior 1 7.00  8 10.63 3.89 
 Drive 1 6.00  8 11.13 2.36 
 Severity 1 2.00  8 4.63 1.66 
        
≥ 20 yrs Behavior 5 10.60 4.04 3 20 1.73 
 Drive 7 10.00 3.32 5 15.2 4.09 
 Severity 7 3.71 1.11 5 6.4 1.52 
        
 
Comparisons between night-time food seeking and mean hyperphagic behavior scores 
Since a portion of the questionnaire used in this study was not validated, as a measure of 
control, comparisons were made between validated and non-validated questions.  One of the main 
areas of interest was to determine if there was a correlation between night-time food seeking 
(question 9 on the non-validated portion of the questionnaire) and an individual’s mean behavior 
score.  The mean behavior score was chosen because question 5 on the validated HQ asked “How 
often does your child get up at night to food seek?” which was categorized as hyperphagic behavior.   
Three parents indicated their child no longer participates in night-time food seeking behavior 
as the food is now locked.  Since these parents did not answer using the responses provided on the 
questionnaire, it was unclear  if these individual’s night time food seeking behaviors would be 
classified as “never”, “rarely”, “sometimes” or “always.” Therefore, a sensitivity analysis was 
performed using the following two assumptions: the behavior occurred “always” and a separate 
analysis assuming the behavior occurred “rarely”.   
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When analyses were performed using only those 20 individuals who answered question 9 on 
the non-validated portion of the questionnaire using the responses provided and answered all other 
questions assessing  hyperphagic behavior, no statistically significant relationship was found 
(p=0.051). However, of note, individuals in the “always” category had the highest mean behavior 
scores (mean =15.75).   
When analyses were performed on those individuals who answered question 9 on our 
questionnaire and answered all questions which were classified under hyperphagic behavior, there 
was no statistically significant difference between the mean hyperphagic behavior score and the 
amount of night-time food seeking (p=0.088).  Although there was no statistically significant 
relationship, those four individuals classified as “always” participating in night-time food seeking 
had the highest mean behavior scores (mean=15.75) and those classified as “food locked” had the 
second highest mean behavior scores (mean =14.667).  Figure 14 provides a graphical representation 
of this data.   
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When analyses were performed grouping those three individuals who reported the food was 
now locked into the “always” category, a statistically significant relationship was found (p=0.04) 
demonstrating increased frequency of night-time food seeking is associated with higher mean 
hyperphagic behavior scores.  Figure 15 provides a graphical representation of this data.   
 
 
Analyses  were performed grouping those three individuals who reported the food was now 
locked into the “rarely” category and  no statistically significant relationship was found between 
increased night-time food seeking and mean hyperphagic behavior scores (p= 0.24).  
Finally, a t-test was performed between individuals who reported their child “never” 
participated in night-time food seeking or “always” participated in night-time food seeking, which 
demonstrated a statistically significant relationship (p=0.029), suggesting the true amount of night-
time food seeking in our SMS individuals lies somewhere in between “never” and “always.” 
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Relationship between amount of food eaten and BMI 
A Fisher’s exact test was performed to determine if there was a relationship between the 
reported amount of food eaten by the SMS individual and their BMI classification.  The p-value for 
this test was, p= 0.397, demonstrating there is no statistically significant relationship between the 
reported amount of food eaten and the BMI classification in our SMS population.   
Relationship between increased interest in food and BMI 
A Fisher’s exact test was performed to determine if there was a relationship between 
increased interest in food and BMI classification.  The p-value for this test was, p= 0.529, 
demonstrating there is no statistically significant relationship between increased interest in food and 
BMI classification in our SMS population 
Relationship between hyperphagia and BMI, hyperphagia and age  
Analyses were also performed comparing individuals whose parent’s reported their child had 
an increased interest in food and those who parents reported their child did not have an increased 
interest in food.   No statistically significant relationships were found between an increased interest 
in food and BMI or age group.  
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DISCUSSION 
Through the work of numerous researchers, the Smith Magenis Syndrome (SMS) 
phenotype has been well described, including its unique and characteristic neurobehavioral 
profile. Although these publications provide invaluable information regarding the phenotype 
of SMS, the majority of SMS related literature is lacking detailed information regarding 
height, weight and BMI.  Due to the lack of detailed information available, the specific aims 
of this project were to (1) characterize the growth of a cohort of individuals with Smith-
Magenis syndrome in order to determine the prevalence of overweight and obesity and (2) 
investigate hyperphagia and related food-seeking behaviors as possible factors related to 
overweight and obesity in individuals with SMS.  
Growth Patterns of Individuals with SMS 
 Specific aim one was addressed through detailed analyses on the growth 
measurements of children and adults with SMS through the use of a retrospective chart 
review and growth data obtained from parental questionnaires.  A minimum of one growth 
measurement was available for 78 individuals with SMS. One of the initial concerns 
regarding the use of a retrospective chart review involved the possibility that the majority of 
the growth data obtained would be of children with SMS and would not provide information 
on the growth of adolescents and adults with SMS. However, the growth data available for 
review ranged from birth parameters to that of an individual 51 years of age.  The wide age 
range allowed for the examination of growth patterns in young children, adolescents and 
adults with SMS, as well as provided information on how the growth of individuals with 
SMS changes over time.    
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Z-scores were helpful in comparing the growth parameters in the SMS population to 
those in the general US population.  For males and females in all age categories, the 
difference in height-for-age mean Z-scores was statistically significant.  This finding clearly 
demonstrates that SMS individuals in this cohort are shorter than individuals in the general 
population.  Both males and females in this cohort of 78 SMS individuals had negative 
height-for-age mean z-scores indicating heights less than the 50th percentile.  This finding 
further supports the findings in published literature regarding decreased linear growth in 
individuals with SMS (Smith et al., 2004).     
To further characterize the significance of height in the SMS cohort, the Z-scores 
were converted into their corresponding growth percentile.  At 0-24 months of age, males 
were at the 10th -25th percentile and fell to the 5th- 10th percentile at age 24 month, then 
remained at the 5th -10th percentile through the ≥ 20years.  These percentile changes show 
that although the linear growth percentile of males with SMS does fluctuate over time, after 
2 years of age, the mean height for males was never greater than the 10th percentile.   
The results of this study slightly contrast to the data published by Smith et al. in 2004 
who found that males with SMS were at 25th percentile for height by the age of 14.  In this 
study, the highest height percentile reached by males occurred at the age of 0-23 months. 
When the height-for-age mean z-score and corresponding percentiles for females are 
examined, their decreased linear growth is even more striking than what was seen in males.  
At age 0-23 months, females were at the 10th -5th percentile.  However, at age 24 months-5 
years, they fall to less than the 3rd percentile and remain less than the 3rd percentile through 
19 years of age.  By the age of ≥ 20 years, females reach the 5th -3rd percentile.   As an 
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individual is considered to have short stature if they are less than or equal to the 5th 
percentile for age (CDC age specific growth charts, 2000), females in this cohort from the 
age of ≥ 24 months have short stature.   
The results of this study regarding height for age percentiles in females are similar to 
those reported by Smith et al., in 2004 in that both Smith et al., and this study found females 
were at the less than 3rd percentile for height by age 12 years.  However, Smith et al., found 
that female with SMS were between the 5th -25th percentiles for height from age 3-7 years, 
whereas this study found that females age 24 months-19years were at less than the 3rd 
percentile for height.   
It is possible that the highest percentile for height for both males and females 
occurred within 0-23 months of age because infants with SMS typically have normal growth 
parameters at birth (Smith & Gropman, 2005).  Although males with SMS in this cohort 
were also at their highest height percentile at 0-24 months, they remained at the 10th -5th 
percentile for almost all of the age ranges examined and did not fall to less than the 3rd 
percentile as was seen in the females.   The discrepancies in height percentile between males 
and females with SMS is most likely related to the fact that in the general population, males 
are taller than females and although both males and females with SMS are shorter than their 
age matched peers, it would be expected that males with SMS may be taller than females 
with SMS solely due to gender differences.    
Both males and females with SMS had negative weight-for-age mean z-score in 
early in infancy.  This finding could be related to the FTT reported in individuals with SMS 
at around 12 months of age (Gropman et al., 1999; Greenberg et al., 1991). At first glance, 
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the changes in weight-for-age mean Z-scores for males and females with SMS are not 
evident as there was no statistically significant difference between the weight-for-age Z-
scores. Although statistical significance was not achieved, the mean weight-for-age Z-scores 
for males and females did increase with age.  Interestingly, males had z-scores less than the 
50th percentile until age 6-11 years and females had z-scores less than the 50th percentile 
until 12 years of age.  By the age of ≥ 20 years males had weight-for-age mean z-scores 
equivalent to the 50-75th percentile and females had weight-for-age mean z-scores 
equivalent to the 75th-95th percentile.   These results confirm those published by Smith et al., 
in 2004 who reported females with SMS were at that or above the 90th percentile for weight 
by the age of 12 years.  However the results of this study did not correspond to those 
published by Smith et al., in 2004 who reported males were at the 90th percentile for weight 
by age 14.   
Although the results of this study do not exactly correspond to those published by 
Smith et al., in 2004, the trends in height and weight are similar.  Both Smith et al., 2004 and 
this study found that males and females with SMS are less than the 50th percentile for height 
in all age groups where as their weight percentiles are as high as the 90th percentile by age 
12 years.  These changes in percentiles from early childhood to adulthood suggest that there 
may be an underlying factor present in both males and females with SMS that causes their 
weight to increase to greater than the 50th percentile sometime during childhood and 
adolescence. This underlying factor may be related to hyperphagia as it was reported by 
72% of parents surveyed in Part II of this study, who felt their child had an increased interest 
in food. The majority of parents (55%) reported their child first showed an increased interest 
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in food at around 5 years of age.  Additional findings related to hyperphagia in this study 
will be discussed in detail later in this discussion.   
For all males, the calculated mean BMI-for-age Z-scores were positive, 
demonstrating the mean-BMI-for-age was greater than the 50th % percentile in all age 
groups.  In age groups 6-11years, 12-19 years and > 20 years, the difference in BMI for age 
mean Z-scores between SMS males and the general population was statistically significant 
(p=0.023, 0.0023 and  0.0018, respectively) demonstrating male SMS individuals are more 
obese than what is expected for their age.  Similar to weight-for-age findings, when 
examining the corresponding BMI-for-age percentiles in individuals <20, an increase in 
percentile over time was appreciated.  At age 24 months to 5 years, males are between the 
50-75th percentiles, then increase to the 90-95th percentile at age 6-11years, remain at the 90-
95th through 19 years and then return to the 85- 90th percentile at age > 20 years.   
Similar to what was found in males, the calculated mean BMI-for-age Z-scores for 
females were also positive, demonstrating the mean-BMI-for-age was greater than the 50th 
percentile in all age groups.  At age groups 24 months – 5 years, 12-19 years and > 20 years, 
the difference in BMI for age mean Z-scores between female controls in the general 
population was statistically significant demonstrating female SMS individuals have higher 
BMIs for their age (p= <0.001, 0.013 and 0.0039, respectively).  Although the changes in 
percentiles in females with SMS are somewhat less striking than the changes seen in males, 
females with SMS age ≥ 20 years were at the 95th -97th BMI percentile, which is the highest 
mean percentile among any age group or gender in this cohort.   
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If abnormal weight is truly a component of the SMS phenotype, then males and 
females would be overweight and often have an obese BMI.  The presence of elevated BMIs 
and obesity was a main finding in this study.  The mean BMI for males’ age ≥ 20 years fell 
within the 85th-90th percentile, corresponding to an overweight BMI.  BMI for females’ age 
≥ 20 fell within the 95-97th percentile, corresponding to an obese BMI.   A possible 
conclusion for this finding is that females with SMS have higher BMI percentiles than males 
with SMS because the prevalence of female obesity in the general population is higher than 
the prevalence of male obesity (Ogden et al., 2006).    
The depressed linear growth of individuals with SMS in this cohort generally 
remains constant throughout the lifespan, as evidenced by a maximum 10th percentile adult 
height for SMS males and maximum 5th percentile adult height for SMS females.  It appears 
that depressed linear growth is a universal feature of the SMS individuals studied in this 
cohort and has also been reported by others studying SMS (Edelman et al., 2007).  
Obesity in the SMS population 
As the prevalence of elevated BMI and obesity continue to increase in the general 
population, it is difficult to assess the significance of the obesity present in this SMS 
population  (Ogden et al., 2006).  Over the past twenty years, the prevalence of obese adults 
in the general population has doubled while the prevalence of obesity in children has tripled 
(Ogden et al., 2006).  As of 2004, 32.2% of US adults were obese and 34.1% were 
overweight (Ogden et al., 2006).   For US children, 16% were overweight and 16% were 
obese (Ogden et al., 2008). The data reported in this study demonstrates obesity is present in 
this cohort of individuals with SMS.  This is evidenced by SMS individuals of all ages 
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having negative height-for- age mean z-scores, positive weight-for-age mean z-score thus 
leading to positive BMI-for-age mean z-scores.  
  The prevalence of elevated BMI and obesity in this study population is similar to 
rates in the general populations. Figure’s 16 -19 provide a graphical illustration of the 
comparison.  However, it is important to keep in mind that although the percentage of 
obesity in SMS adults is similar to that of the general population, the height of individuals 
with SMS are significantly shorter than those of males and females in the general 
population.  The average height of an adult male is 5’9½”and the average height of an adult 
female is 5’4” (Ogden et al., 2004).  This is in contrast to the average height of males in this 
study of 5’3” and the average height of females in this study of 5’0”.     
What is perhaps most striking about the growth data obtained from the parent 
questionnaire regarding growth of children and adolescents, is the prevalence of elevated 
BMI and frank obesity.  In the data obtained from the parent questionnaire, 50% of children 
and adolescents were either overweight or obese, compared with 32% of US children and 
adolescents within  the general population classified as overweight or obese (Ogden et al., 
2008).   
The underlying etiology leading to increased BMIs during childhood and adolescents 
is not known.  Additionally, it is unknown whether or not hyperphagia is the cause of 
obesity in SMS or is simply an effect of an underlying biochemical defect that predisposes 
individuals with SMS to develop elevated BMIs and obesity.  Although it was beyond the 
scope of this project, the role of biochemical markers and their association with the 
development of obesity should be investigated.  Future studies regarding obesity and SMS 
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should consider the prospective measurement of biochemical markers known to be 
associated with obesity including the following: ghrelin, leptin, insulin, HDL and LDL.  A 
prospective examination would aid in the determining the time at which elevated BMIs and 
obesity occurs in SMS.    
82 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Healthy 
Weight
34%
Overweight
29%
Obese
37%
Figure 16. Obesity in US Adults
O
Ogden et al., 2006
 
Healthy 
Weight
39%
Overweight
38%
Obese
23%
Figure 17.BMI in SMS Adults,  n= 13
Data from Questionnaire
 
Healthy 
Weight
68%
Overweight
16%
Obese
16%
Figure 18. Obesity in US Children & 
Adolescents
Ogden et al., 2008 
 
Healthy 
Weight
50%
Overweight
8%
Obese
42%
Figure 19. BMI in SMS children and 
adolescents, n=12
Data from Questionnaire
83 
 
Part II-Parent Questionnaire 
It has been anecdotally reported that obesity is present in individuals with SMS; 
however, there is little to no documented evidence of this and no possible explanation for 
the cause of this trend.  This study hypothesized that if abnormally elevated BMIs are 
present in individuals with SMS, hyperphagic behaviors may be involved in this phenotype. 
Thus, specific aim two of this study involved the use of a parent questionnaire, including the 
validated Hyperphagia Questionnaire (HQ), to explore the role of hyperphagia in individuals 
with SMS (Dykens et al., 2007).     
The results obtained from the questionnaire portion of this study indicate 
hyperphagia and related abnormal food behaviors may be problematic in SMS, as 72% of 
parents reported their child had an increased interest in food and 76 % of parents indicated 
they had to lock food away from their child.   When asked about the frequency of their 
child’s night-time food seeking behaviors, three parents indicated that their child no longer 
participated in night-time food seeking because the food is now locked and the child is no 
longer able to assess it.  One parent indicated, prior to locking the kitchen, her child’s night-
time food seeking was constant and her child still continues to frequently hoard food in her 
room.    
Hyperphagia Questionnaire (HQ) 
 The HQ was first used to measure hyperphagia in individuals with Prader-Willi 
syndrome (Dykens et al., 2007).  Hyperphagia is universally present in individuals with 
PWS and without intensive dietary monitoring; individuals with PWS will become morbidly 
obese (Holm, Cassidy, Butler, Hanchett, Greenswag, & Greenberg, 1993).  The underlying 
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etiology of obesity in PWS is not definitively known, but it is thought to be caused by 
satiety dysfunction (Lindgren et al., 2000).  
The HQ is scored on a Likert scale, ranging from 1 to 5.   A score of 1 on any given 
question equates to the behavior as being “not a problem” and a score of 5 on any given 
question equates to the behavior being a “severe and/or frequent problem” (Dykens et al., 
2008).  When the HQ was used in the PWS population, the mean scores ranged from 1.80 on 
question 4, which asked: “How often does your child forage through the trash for food?” to 
4.05 on question 10, which asked: “How clever or fast is your child in obtaining food?” The 
majority of the mean scores obtained on the HQ ranged from 2.20-2.24 to 3.06 to 3.34 
(Dykens et al., 2007). 
In this study, the mean scores obtained on the HQ ranged from 1.28 on question four,  
(“How often does your child forage through the trash for food?”) to as high as 3.12 on 
question six, (“ How persisent is your child in asking or looking for food when told No?” ) 
The majority of the mean scores for the questions on the HQ ranged from 2.4 to 2.6, 
suggesting that, for the most part, the behaviors assessed for on the HQ were at a minumum, 
“somewhat of a problem” for the majority of SMS individuals whose parents’completed the 
HQ.   
Age and its relationship with hyperphagic tendencies were explored and found not to 
be significantly associated with increased hyperphagic behavior, drive or severity.  The 
absence of a statistically significant association between age and hyperphagic tendencies in 
this study is in contrast to the statistically significant positive association between age and 
hyperphagic tendencies in the PWS patient population (Dykens et al., 2007.) Although 
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statistical significance between age and mean hyperphagic behavior, drive and severity 
scores was not reached, age does appear to influence hyperphagic tendencies in SMS.  This 
is evidenced by individual’s ≥ 20 years of age having the highest mean behavior, drive and 
severity scores and individuals in the youngest age category of 6-11 years having the lowest 
mean behavior, drive and severity scores. Evidence that supports the hypothesis that 
hyperphagic tendencies may increase with age come from the results obtained in Part I of 
this study which demonstrates as individuals with SMS age, their BMI’s also increase, even 
into the overweight and obese ranges.    
Because Dykens et al. considered gender and its relationship to mean hyperphagic 
behavior, drive and severity scores in individuals with PWS, the effects of gender were also 
examined in this cohort of SMS individuals.  Surprisingly, a statistically significant 
relationship was found between gender and mean hyperphagic severity scores with females 
having higher mean scores when compared to males (p= 0.038).   Although not statistically 
significant, females also had higher mean behavior and drive scores when compared to 
males.  No statistically significant relationship was found between gender and mean 
hyperphagic behavior, drive or severity scores in the PWS patient population (Dykens et al., 
2007).   
Due to differences between gender and age distribution within our study population 
when the data for behavior, drive and severity scores were reanalyzed after adjusting age 
and gender for each other, stratification by age and gender showed the mean behavior, drive 
and severity scores for females were higher than males in all age groups and that females 
age ≥ 20 had the highest mean behavior, drive and severity scores.  These data confirm 
similar published reports of females demonstrating  more severe hyperphagic tendencies as 
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Edelman et al., (2007) reported “eating/appetite problems” 69.2% of females and only 
21.4% of males.   
The age of onset of hyperphagia was also considered.  Eighteen out of twenty-five 
parents (72%) reported their child had an increased interest in food.  As the age reported at 
which their child showed an increased interest in food spanned from 1 year of age to 34 
years of age, it was difficult to pinpoint when exactly increased interest in food began.   
However upon closer examination, the majority of parents (55.5%) reported their child 
showed at increased interest in food between 1 and 5 years of age, suggesting there may be 
an underlying behavioral component involved in the age of onset of increased interest in 
food that becomes evident during early childhood. This increase in interest in food may be 
related to the fact that prior to around 5 years of age the diet of a child is primarily 
controlled by their parent and the increase interest in food may be related to children 
becoming more aware of their environment and asserting more control over their food 
choices.   
As no previous studies have systematically examined the role of hyperphagia in 
individuals with SMS, it is unclear if data regarding age of onset of hyperphagia reported in 
this study is representative of age of onset of hyperphagia in the SMS population as a whole.  
In the use of the HQ in the PWS patient population, the reported mean age of onset of 
hyperphagia was 3.5 ± 1.6 years, with a range of 1.5 to 7 years (Dykens et al., 2007).   Since 
the age of onset of hyperphagia occurs at a younger age in the PWS population, and within a 
better defined age range, it appears hyperphagia in SMS may be more variable in severity 
and age of onset than in individuals with PWS.   
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Another item which was examined separately was the variability in hyperphagic 
symptoms.  The majority of parents (75%) also felt there was little to no variability in their 
child’s interest in food suggesting any preoccupation or interest in food present in their 
children with SMS is not affected by outside factors such as stress or emotion.   These are 
two factors which are well known to effect eating behavior (Geliebter & Aversa, 2003).  The 
lack of reported variability in their child’s preoccupation with food suggests hyperphagia 
may be an inherent component of the SMS phenotype.  Similar findings of stable 
preoccupation with food in the PWS population also support the notion hyperphagia is an 
inherent aspect of the SMS phenotype (Dykens et al., 2007; Holm, Cassidy, Butler, 
Hanchett, Greenswag, & Greenberg, 1993).   
It appears that foraging through the trash for food is present only in a small 
percentage (n=4;16%) of our respondents. It is most likely not present in the high frequency 
seen in the PWS patient population.   The vast majority of parents, 88%, also felt food-
related thoughts, talk or behavior had either mild to no interference with their child’s normal 
daily routines, self-care, food or work.  This suggests the possible negative effects of food-
related thoughts, talk and behavior are minimal.   
The results obtained from the questionnaire portion of this study indicate 
hyperphagia or related abnormal food behaviors may be problematic in SMS, as 72% of 
parent’s reported their child had an increased interest in food. Perhaps more surprising was 
that 76 % of parent’s indicated; when specifically asked, that they had to lock food away 
from their child.   Not all parents in this study indicated their child had an increased interest 
in food, suggesting that although hyperphagia and related abnormal food behaviors are 
present in a large portion of SMS individuals examined in this study, hyperphagia may or 
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may not be a universal feature of SMS.  It is most likely that a combination of numerous 
factors including environment, lifestyle as well as a hyperphagia component are involved in 
the development of increased BMIs overweight and obesity in individuals with SMS.    
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Strengths of Study 
 The results of Part I of this study provide detailed information on the growth of 78 
individuals with SMS.  As there is limited information available regarding the growth of 
individuals with SMS, the ability to report detailed information on the growth of 78 
individuals certainly increases the knowledge of a portion of the SMS phenotype that is less 
well known.  In comparison to the growth data reported in the medical literature, the 
information provided in this study is much more comprehensive and detailed.  The large 
meta-analysis published by Edelmann et al., in 2007 provided valuable information about 
genotype-phenotype information in individuals with SMS but was lacking comprehensive 
information regarding growth in individuals with SMS. In over 60% of the cases examined, 
information regarding growth and BMI was unavailable.  An abstract presented by Smith et 
al. in 2004 provided an overview of parametric measurements of height and weight in 54 
individuals with SMS. Detailed information regarding BMI was not provided.  However, it 
was stated that “BMI values were variable across ages” (Smith et al., 2004). Although this 
abstract was able to report on how the different height and weight percentile of individuals 
with SMS change over time, information regarding the number of individuals in each age 
category was not available.  This study overcame the limitations described in the two 
previous publications by reporting detailed information regarding the height and weight of 
78 individuals with SMS. This study was also able to report on how the BMI of 74 
individuals with SMS change over time, as there were only 4 individuals in this study who at 
last recorded measurement were less than 24 months of age.     
 Part II of this research project serves as a pilot study, as there is no published 
literature which assesses for possible causes of overweight and obesity in individuals with 
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SMS.  Thus, one of the major strengths of this study is that it is the first to assess the role of 
hyperphagia in individuals with SMS as well as its relationship to the presence of elevated 
BMIs and obesity.  An additional strength of this study is that a validated instrument, the 
HQ, was used to assess hyperphagia.  The HQ was initially used in the PWS patient 
population and was able to quantify the universal aspects of the PWS phenotype related to 
hyperphagia.  Not surprisingly, the majority of the mean scores on the HQ were lower in the 
SMS population compared to the PWS population.  A result which was somewhat surprising 
was that the mean score on a few of the questions on the HQ were actually higher than the 
mean scores in the PWS patient population.  These results demonstrate that hyperphagia is 
present in SMS and that the HQ was able to capture the hyperphagic characteristics of the 
SMS phenotype.   
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Limitations 
The primary limitation in the chart review used in this study was that the majority of 
individuals (61.5%) had only one or two growth measurements available for analysis, and 
many were not recent measurements.  The lack of multiple growth measurements at similar 
time points for each individual possibly limited the ability to truly assess how these 
individuals height, weight and BMI change over time.  Another possible limitation involves 
the growth measurements obtained on the parent questionnaire.  Although we are confident 
that the height and weight data abstracted from the medical record was collected using 
standard procedures, the same cannot be said for the information obtained from parents’ self 
report.  It is unknown how parents measured their child’s height and weight, and it is 
possible the parent did not truly measure their child’s weight, but rather estimated them.   
The primary limitation related to the parent questionnaire is the small sample size.  It 
is possible that due to the small sample size, the results regarding hyperphagia in individuals 
with SMS are not truly representative of the SMS population as a whole.  It is perhaps 
difficult to assess the results of this study in terms of the implications for the SMS 
community as a whole, as is the first study designed to specifically assess hyperphagia in 
individuals with SMS.  Thus, comparisons between previous studies cannot be made.  In 
addition, the responses on the HQ are taken from parents’ self report of their child’s eating 
behaviors.  It is well known that parents commonly underestimate the severity of abnormal 
behaviors present in their child and the same could possibly be said for the hyperphagic 
tendencies assessed for in this study.  One potential way to overcome this limitation would 
be to administer the HQ to parents of children with SMS as well as other individuals 
involved in the child’s life including, physicians, nurses or other care providers and compare 
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the results in hopes of obtaining results that are truly representative of the child’s 
hyperphagic tendencies.  Another potential limitation involves the fact that this 
questionnaire was mailed to parents and not administered in person as was the case when the 
HQ was used in the PWS population.  It is possible parents may have been confused 
regarding the meaning of some of the questions on the HQ and may have left that question 
blank or answered the question incorrectly.  Administering the HQ in person would allow 
for discussion regarding the questions on the HQ as well as ensure that every question on the 
HQ was answered.   
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Future Studies 
The finding of females’ age ≥ 20 years of age having the highest mean behavior, 
drive and severity scores as well as the highest BMIs, leads us to further consider the 
relationship between hyperphagia and elevated BMIs and obesity.  An interesting future 
study could involve prospective examination of a cohort of males and females with SMS.  
The use of a prospective study would provide information on whether or not the 
hyperphagia developed first and thus contributed to the development of elevated BMIs and 
obesity.  It is also possible that elevated BMIs and obesity developed for other reasons and 
the presence of hyperphagia in this cohort is simply an effect of the obesity.  The use of a 
prospective study would also allow for the examination of biochemical markers associated 
with obesity including leptin, insulin, HDL and LDL.  The prospective examination of 
biochemical markers would be able to provide information regarding whether or not 
hyperphagia or obesity develops first in SMS.   
Another potential avenue to explore for future research would be to re-contact those 
parents who indicated their child had an increased interest in food to further investigate this 
response.  Since there is room for interpretation of “an increased interest in food” targeted 
questions would be helpful.  A third area for future research would be to re-contact those 
parents who indicated they had to lock food away from their child  to learn what behaviors 
exhibited by their children precipitated the need to lock food away and at what age they 
began locking the food away.  Knowledge of this information may aid in pinpointing the age 
of onset of hyperphagia in SMS so that measures can be taken to control hyperphagia and in 
turn hopefully to control elevated BMIs and obesity.  It would also be interesting to look 
closely at those individuals who, by parent report, had an increased interest in food to see if 
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those individuals have higher rates of the negative health consequences known to be 
associated with obesity. 
A potential research project unrelated to SMS, but still relevant to the topic of 
elevated BMIs and obesity, would be to perform a study using the HQ in the general 
population.  It would be interesting to see how the parents of children without genetic 
disorders interpret their child’s food related behaviors, both “normal” and “abnormal” as 
well as how the mean behavior, drive and severity scores are different based on weight 
status of individuals in the general population.   
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Conclusion 
The results obtained in Part I of this study demonstrated short stature and a 
concomitant increase in weight leading to BMI percentiles in the overweight and obese 
range in individuals with SMS.  Elevated BMIs were present in both males and females with 
SMS, though females tended to have higher BMIs.  The results of Part II of this study, the 
parent questionnaire, also indicated that hyperphagia was present in individuals with SMS as 
evidenced by 76% of parents’ reporting having to lock food away from their child.    
The information gained regarding the presence of hyperphagia in individuals with 
SMS, as well as the propensity to develop elevated BMIs, provides healthcare professionals 
with valuable information regarding a component of the phenotype of SMS which has not 
been well described. This increase in knowledge will hopefully enable parents and 
caregivers of children with SMS to take preventative measures in order to control any 
hyperphagic tendencies present in their child and subsequently prevent the onset of obesity.  
Although the severity of hyperphagia present in individuals with SMS does not reach 
the levels present in individuals with PWS, as individuals with PWS have died from to  
complications related to uncontrolled hyperphagic behaviors, the negative health 
consequences of elevated BMIs and obesity are still a concern (Stevenson et al., 2007).  
There are currently no dietary or exercise guidelines in place for individuals with SMS.  The 
results of this study indicating the presence of elevated BMIs and obesity as well as 
hyperphagia, may indicate the need for increased dietary monitoring in individuals with 
SMS.   
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APPENDIX 1: QUESTIONNAIRE 
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Please make sure to complete the form to the best of your ability. If you do not wish to 
answer a question or are unsure of how to answer, please leave the question blank. 
 
A. DEMOGRAPHIC INFORMATION REGARDING INDIVIDUAL WITH SMITH-
MAGENIS SYNDROME (SMS) 
 
1.) NAME:   ___________________    ____________________  
 Last         First 
2.) Date of Birth:    ________   _______   ________ 
           Month       Day           Year 
 
B. DEMOGRAPHIC INFORMATION, To be completed by parent/guardian of the 
individual with SMS named above 
1.) What is your age?  ________ 
 
2.)  What is your gender? 
  Male   
  Female  
 
3.)  What is your ethnicity? 
  White   
  Black  
  Hispanic 
  Native American  
  Asian 
  Other, please specify __________________ 
 
 
 
98 
 
4.) What is your primary language? 
  English 
  Spanish  
  Other 
 
5.) What is your relationship to the child with Smith-Magenis syndrome? 
  Mother  
  Father  
  Step-mother 
  Step-father 
  Biological grandmother 
  Biological grandfather 
  Other, please specify __________________ 
 
6.) What is your current marital status? 
  Single  
  Married or living as married  
  Separated 
  Divorced  
  Widowed 
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7.) What is the grade of schooling you have completed? 
  8th grade or less  
  9th to 11th grade  
  High School or GED 
  Some college 
  Associates Degree (2 yr) 
  Bachelor’s Degree 
  Advanced Degree 
  No formal education 
 
8.) Are you currently employed? 
  Yes   No 
If yes, what is your current occupation? _________________________________ 
If no, how long have you been unemployed?  _____________________________ 
 
9.) How many hours a week do you work in your current occupation? 
  Fewer than 10  
  10-20 hours  
  20-40 hours 
  More than 40 hours 
 
10.) Which comes closest to the current average total annual income for your entire 
household before taxes. Please include the income from everyone in your household, 
  Less than $25,000 
  $25,000- $50,999  
  $100,000- more 
  Prefer not to answer 
  $51,000-$74,999            
  $75,000- $99,999 
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C.  MEDICAL AND SOCIAL HISTORY REGARDING INDIVIDUAL WITH 
SMITH-MAGENIS SYNDROME (SMS) 
1.) What is your child’s current height? 
__________Ft   __________in 
 
2.) What is your child’s current weight? 
__________lbs 
 
3.) How old was your child when he/she were diagnosed with SMS? 
__________ Years __________months  
 
 
4.) Who made the initial diagnosis of SMS (choose one)? 
Primary Care/Pediatrician 
Geneticist 
Neurologist 
Developmental Specialist  
 Other (Please Specify): ____________________ 
 
5.) What were the results of the genetic testing? 
 17p11.2 deletion 
 RAI1 mutation 
 Don’t know 
  
6.) Was your child ever given a diagnosis of failure to thrive (FTT) during infancy? 
 Yes     
 No 
 Don’t know 
 
 
7.) Did your child ever need to have a feeding tube placed? 
 Yes     
 No 
 Don’t know 
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8.) If  yes, (that your child had a feeding tube) did he/she have a g-tube placed surgically? 
 Yes     
 No 
 Don’t know 
 
 
9.) Was your child born with or diagnosed with any of the following?  
Cleft lip    Yes     No Kidney defect                  Yes      No 
Cleft palate   Yes     No Urinary tract defect          Yes    No 
Heart defect   Yes      No  Low thyroid function       Yes    No 
 
 
10.) Has your child ever taken medication for any of the following? 
Heart Defects   Yes     No       Anxiety                                Yes       
No 
Seizures   Yes     No       Depression                               Yes       
No 
Diabetes    Yes     No      Hyperactivity/ADD                         Yes       
No 
High cholesterol  Yes     No       Sleep Disturbances                          Yes       
No 
High blood pressure  Yes      No      Self-injurious behavior                   Yes       
No 
Thyroid problems  Yes    No        Aggression                               Yes       
No 
Kidney problems  Yes    No        Obsessive compulsive behaviors   Yes        
No  
Acid reflux   Yes     No        Kidney reflux                    Yes       
No            
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11.)  Has your child ever taken any medications that have affected his/her appetite, weight or 
activity level?  If yes, please list the medication and circle the appropriate effect:    
Medication 
Name 
(please list) 
Change in Weight Change in Appetite Change in Level of  Physical Activity  
 Increase Decrease Increase Decrease Increase Decrease 
 Increase Decrease Increase Decrease Increase Decrease 
 Increase Decrease Increase Decrease Increase Decrease 
 Increase Decrease Increase Decrease Increase Decrease 
 
12.)  Is there a family history of any of the following? Please check all that apply: 
 Overweight 
 Obesity 
 Hypertension 
 Diabetes  
 Pre-diabetes 
 High cholesterol 
 Heart disease 
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For questions 13-15, please check just one box for each question. 
13.)  Where does your child with SMS currently live? 
 At home 
 In a group home/assisted living facility 
 Other, please specify _________________ 
 
14.) What is the highest level of schooling that your child has completed? 
       Elementary school 
  Middle school 
  High school  
15.)  Did your child receive assistance in school? 
 Yes   
 No  
 
C. EXERCISE HISTORY:  
 
1.) Does your child have an exercise program/physical activity program? 
 Yes     
 No 
My child: 
walks/runs  ___ times per week  for ____ minutes each time 
swims   ___ times per week  for ____ minutes each time 
plays outside ___ times per week  for ____ minutes each time 
rides bicycle  ___ times per week  for ____ minutes each time 
other (please list below)    
___________ times per week  for ____ minutes each time  
____________ times per week  for ____ minutes each time  
 
2.) My child is able to exercise but he/she does not have a regular routine: 
 
 Yes       No
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3.) My child is unable to exercise due to: 
 Severe joint pain 
 Shortness of breath  
 Scoliosis   
 Muscle weakness   
 Will not participate in physical activity 
 Other, please specify ________________________________________ 
____________________________________________________________ 
 
D. DIETARY HISTORY:  
 
1.) Do you consider your child to have a daily eating pattern similar to other children his/her 
age?  
 Yes      No 
 
2.) Which meals does your child eat each day? Please check all that apply 
 Breakfast  
 Lunch  
 Dinner  
 Snacks  
 
3.) Do you feel your child eats: 
Less than normal amounts of food 
Normal amounts of food 
Greater than normal amounts of food  
4.) Does your child binge eat? 
 Yes      No 
 
5.) Does your child snack?  
 Yes  
    
 No 
6.) Does your child eat/snack just before bedtime?  
 Yes    
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   No 
 
7.) What are your child’s top 3 favorite snacks?  
________________________________ 
________________________________ 
________________________________ 
 
8.) How often does your child wake up during the night?  
 0-1 times per night 
 2-3 times per night   
 4-5 times per night  
 > 5 times per night  
9.) Of the times that your child wakes up during the night, how often does he or she eat? 
 Never 
 Rarely 
 Occasionally   
 Always  
10.) Do you ever or have you ever had to lock food away from your child?  
 Yes   
 No
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11.) How upset does your child generally become when denied a desired food? 
 Not particularly upset at all 
 A little upset 
 Somewhat upset 
 Very upset 
 Extremely upset 
 
12.) How often does your child try to bargain or manipulate to get more food at meals? 
 A few times a year 
 A few times a month 
 A few times a week 
 Several times a week 
 Several times a day 
 
13.) Once your child has food on their mind, how easy is it for you or others to re-direct 
your child away from food to other things? 
 Extremely easy, takes minimal effort to do so 
 Very easy, takes just a little effort to do so 
 Somewhat hard, takes some effort to do so 
 Very hard, takes a lot of work to do so 
 Extremely hard, takes sustained and hard work to do so 
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14.) How often does your child forage (look/search) through the trash for food? 
 Never 
 A few times a year 
 1–2 times a month 
 1–3 times a week 
 4 to 7 times a week 
 
15.) How often does your child get up at night to food seek? 
 Never 
 A few nights a year 
 1–2 nights a month 
 1–3 nights a week 
 4 to 7 nights a week 
 
16.)  How persistent is your child in asking or looking for food after being told “no” or “no 
more”? 
Lets go of food ideas quickly and easily 
Lets go of food ideas pretty quickly and easily 
Somewhat persistent with food ideas 
Very persistent with food ideas 
Extremely persistent with food ideas 
 
17.)  Outside of normal meal times, how much time does your child spend talking about 
food or engaged in food-related behaviors? 
Less than 15 minutes a day 
15 to 30 minutes a day 
30 minutes to an hour 
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1 to 3 hours a day 
More than 3 hours a day 
 
18.)  How often does your child try to steal (take when told not to) food (that you are aware 
of?) 
A few times a year 
A few times a month 
A few times a week 
Several times a week 
Several times a day 
 
19.)  When others try to stop your child from talking about food or engaging in food-related 
behaviors, it generally leads to: 
No distress or upset 
Mild distress or upset 
Moderate distress or upset 
Severe distress or upset 
Extreme distress, behaviors can’t usually be stopped 
 
20.)  How clever or fast is your child in obtaining food? 
Not particularly clever or fast 
A little clever or fast 
Somewhat clever or fast 
Very clever or fast 
Extremely clever of fast 
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21.) To what extent to food-related thoughts, talk, or behavior interfere with your child’s 
normal daily routines, self-care, school, or work? 
No interference 
Mild interference; occasional food-related interference in completing school, 
work, or hygiene tasks 
Moderate interference; frequent food-related interference in completing school, 
work, or hygiene tasks 
Severe interference; almost daily food-related interference in completing school, 
work, or hygiene tasks 
Extreme interference, often unable to participate in hygiene tasks or to get to 
school or work due to food-related difficulties 
 
22.)  How old was your child when he/she first showed an increased interest in food? 
___ years  
  My child does not have an increased interest in food 
 
23.)  How variable is your child’s preoccupation or interest in food? 
Hardly ever varies 
Usually stays about the same 
Goes up and down occasionally 
Goes up and down quite a lot 
Goes up and down all the time 
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